<SEC-DOCUMENT>0001104659-24-024562.txt : 20240215
<SEC-HEADER>0001104659-24-024562.hdr.sgml : 20240215
<ACCEPTANCE-DATETIME>20240215164222
ACCESSION NUMBER:		0001104659-24-024562
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		17
CONFORMED PERIOD OF REPORT:	20240210
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20240215
DATE AS OF CHANGE:		20240215

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Cryoport, Inc.
		CENTRAL INDEX KEY:			0001124524
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				880313393
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-34632
		FILM NUMBER:		24644430

	BUSINESS ADDRESS:	
		STREET 1:		112 WESTWOOD PLACE, SUITE 350
		CITY:			BRENTWOOD
		STATE:			TN
		ZIP:			37027
		BUSINESS PHONE:		(949) 232-1900

	MAIL ADDRESS:	
		STREET 1:		112 WESTWOOD PLACE, SUITE 350
		CITY:			BRENTWOOD
		STATE:			TN
		ZIP:			37027

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CRYOPORT SYSTEMS LLC
		DATE OF NAME CHANGE:	20010614

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CRYOPORT SYSTEMS INC
		DATE OF NAME CHANGE:	20000923
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>tm246433d1_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:us-roles="http://fasb.org/us-roles/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:cyrx="http://Cryoport.com/20240210">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02C_US%2DGAAP%2D2023 -->
<!-- Field: Set; Name: xdx; ID: xdx_037_cyrx_Cryoport.com_20240210 -->
<!-- Field: Set; Name: xdx; ID: xdx_049_20240210_20240210 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DEntityCentralIndexKey_0001124524 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2024-02-10" name="dei:AmendmentFlag" id="ixv-344">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2024-02-10" name="dei:EntityCentralIndexKey" id="ixv-345">0001124524</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="cyrx-20240210.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2024-02-10">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001124524</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-02-10</xbrli:startDate>
        <xbrli:endDate>2024-02-10</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="margin: 0"></p>


<p style="margin: 0pt 0">&#160;</p>

<!-- Field: Rule-Page --><div style="margin-top: 0; margin-bottom: 0; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><p style="margin: 0pt 0">&#160;</p>


<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES</b></p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Washington, DC&#160;20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b>&#160;</p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM <span id="xdx_906_edei--DocumentType_c20240210__20240210_zj4AtTOATRA5"><ix:nonNumeric contextRef="AsOf2024-02-10" name="dei:DocumentType" id="ixv-365">8-K</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;<b>Pursuant to Section 13 or 15(d)
of the</b><br/>
<b>Securities Exchange Act of 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Date of Report (Date of earliest event reported): <b><span id="xdx_90F_edei--DocumentPeriodEndDate_c20240210__20240210_zZTZxAQAxnxa"><ix:nonNumeric contextRef="AsOf2024-02-10" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="ixv-366">February 10, 2024</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 18pt"><b><span id="xdx_905_edei--EntityRegistrantName_c20240210__20240210_zO1gXyGL1WX7"><ix:nonNumeric contextRef="AsOf2024-02-10" name="dei:EntityRegistrantName" id="ixv-367">CRYOPORT, INC.</ix:nonNumeric></span></b></span><b><span style="font-size: 10pt">&#160;</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact name of registrant as specified in its charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="vertical-align: top; width: 33%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_90A_edei--EntityIncorporationStateCountryCode_c20240210__20240210_z4Kyqh88fcj1"><ix:nonNumeric contextRef="AsOf2024-02-10" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="ixv-368">Nevada</ix:nonNumeric></span></b></span></td>
    <td style="vertical-align: bottom; width: 1%">&#160;</td>
    <td style="vertical-align: top; width: 32%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_902_edei--EntityFileNumber_c20240210__20240210_z5E6PtRRXFyd"><ix:nonNumeric contextRef="AsOf2024-02-10" name="dei:EntityFileNumber" id="ixv-369">001-34632</ix:nonNumeric></span></b></span></td>
    <td style="vertical-align: top; width: 1%; text-align: center">&#160;</td>
    <td style="vertical-align: top; width: 33%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_904_edei--EntityTaxIdentificationNumber_c20240210__20240210_zPx97TdPSxfl"><ix:nonNumeric contextRef="AsOf2024-02-10" name="dei:EntityTaxIdentificationNumber" id="ixv-370">88-0313393</ix:nonNumeric></span></b></span></td></tr>
<tr>
    <td style="vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(State or other jurisdiction<br/>
of incorporation)</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(Commission File Number)</span></td>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(IRS Employer<br/>
Identification No.)</span></td></tr>
<tr>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td></tr>
<tr style="vertical-align: top">
    <td colspan="5" style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_909_edei--EntityAddressAddressLine1_c20240210__20240210_zfeSDGdqtmR4"><ix:nonNumeric contextRef="AsOf2024-02-10" name="dei:EntityAddressAddressLine1" id="ixv-371">112 Westwood Place</ix:nonNumeric></span>, <span id="xdx_90C_edei--EntityAddressAddressLine2_c20240210__20240210_zltaphT85xWb"><ix:nonNumeric contextRef="AsOf2024-02-10" name="dei:EntityAddressAddressLine2" id="ixv-372">Suite 350</ix:nonNumeric></span><br/><span id="xdx_90D_edei--EntityAddressCityOrTown_c20240210__20240210_zclplzTl7rse"><ix:nonNumeric contextRef="AsOf2024-02-10" name="dei:EntityAddressCityOrTown" id="ixv-373">Brentwood</ix:nonNumeric></span>, <span id="xdx_908_edei--EntityAddressStateOrProvince_c20240210__20240210_zgfKJp4l9ZAk"><ix:nonNumeric contextRef="AsOf2024-02-10" name="dei:EntityAddressStateOrProvince" id="ixv-374">TN</ix:nonNumeric></span> <span id="xdx_909_edei--EntityAddressPostalZipCode_c20240210__20240210_zuEQny2iucuh"><ix:nonNumeric contextRef="AsOf2024-02-10" name="dei:EntityAddressPostalZipCode" id="ixv-375">37027</ix:nonNumeric></span></b></span></td></tr>
<tr style="vertical-align: top">
    <td colspan="5" style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(Address of principal executive offices, including zip code)</span></td></tr>
<tr>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td></tr>
<tr style="vertical-align: top">
    <td colspan="5" style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Registrant&#8217;s telephone number, including area code: <b>(<span id="xdx_907_edei--CityAreaCode_c20240210__20240210_z8T78YSOEP27"><ix:nonNumeric contextRef="AsOf2024-02-10" name="dei:CityAreaCode" id="ixv-376">949</ix:nonNumeric></span>) <span id="xdx_904_edei--LocalPhoneNumber_c20240210__20240210_zgEsxTnwsiJa"><ix:nonNumeric contextRef="AsOf2024-02-10" name="dei:LocalPhoneNumber" id="ixv-377">470-2300</ix:nonNumeric></span></b></span></td></tr>
<tr style="vertical-align: top">
    <td colspan="5" style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: top">
    <td colspan="5" style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Not Applicable</b></span></td></tr>
<tr style="vertical-align: top">
    <td colspan="5" style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(Former name or former address, if changed since last report)</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction
A.2. below): <span style="font-family: Wingdings"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
<tr style="vertical-align: top; text-align: justify">
    <td style="width: 0in"/>
    <td style="width: 0.25in; text-align: left"><span style="font: 10pt Wingdings"><span style="font-family: Wingdings"><span id="xdx_900_edei--WrittenCommunications_c20240210__20240210_zBKuaza8cFK4"><ix:nonNumeric contextRef="AsOf2024-02-10" format="ixt:booleanfalse" name="dei:WrittenCommunications" id="ixv-378">&#168;</ix:nonNumeric></span></span></span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr>
</table>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
<tr style="vertical-align: top; text-align: justify">
    <td style="width: 0in"/>
    <td style="width: 0.25in; text-align: left"><span style="font: 10pt Wingdings"><span style="font-family: Wingdings"><span id="xdx_906_edei--SolicitingMaterial_c20240210__20240210_zLJeoOtNZuOe"><ix:nonNumeric contextRef="AsOf2024-02-10" format="ixt:booleanfalse" name="dei:SolicitingMaterial" id="ixv-379">&#168;</ix:nonNumeric></span></span></span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
</table>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
<tr style="vertical-align: top; text-align: justify">
    <td style="width: 0in"/>
    <td style="width: 0.25in; text-align: left"><span style="font: 10pt Wingdings"><span style="font-family: Wingdings"><span id="xdx_901_edei--PreCommencementTenderOffer_c20240210__20240210_z9lOuw5un2Wa"><ix:nonNumeric contextRef="AsOf2024-02-10" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer" id="ixv-380">&#168;</ix:nonNumeric></span></span></span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
</table>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
<tr style="vertical-align: top; text-align: justify">
    <td style="width: 0in"/>
    <td style="width: 0.25in; text-align: left"><span style="font: 10pt Wingdings"><span style="font-family: Wingdings"><span id="xdx_902_edei--PreCommencementIssuerTenderOffer_c20240210__20240210_z8pDeQdT95od"><ix:nonNumeric contextRef="AsOf2024-02-10" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer" id="ixv-381">&#168;</ix:nonNumeric></span></span></span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20.25pt; text-indent: -0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Securities registered pursuant to Section
12(b) of the Act:</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; width: 34%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Title of each class</b></span></td>
    <td style="width: 1%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 32%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Trading Symbol</b></span></td>
    <td style="width: 1%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 32%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Name of each exchange on which <br/>
registered</b></span></td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_905_edei--Security12bTitle_c20240210__20240210_zM5iRvrBMfKg"><ix:nonNumeric contextRef="AsOf2024-02-10" name="dei:Security12bTitle" id="ixv-382">Common Stock, $0.001 par value</ix:nonNumeric></span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_900_edei--TradingSymbol_c20240210__20240210_zalKMBp7JANa"><ix:nonNumeric contextRef="AsOf2024-02-10" name="dei:TradingSymbol" id="ixv-383">CYRX</ix:nonNumeric></span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_909_edei--SecurityExchangeName_c20240210__20240210_zGE9GBF08bbe"><ix:nonNumeric contextRef="AsOf2024-02-10" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="ixv-384">The NASDAQ Stock Market LLC</ix:nonNumeric></span></span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter). Emerging growth company <span style="font-family: Wingdings"><span id="xdx_904_edei--EntityEmergingGrowthCompany_c20240210__20240210_zVov7UTQOLmd"><ix:nonNumeric contextRef="AsOf2024-02-10" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany" id="ixv-385">&#168;</ix:nonNumeric></span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="font-family: Wingdings">&#168;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<!-- Field: Rule-Page --><div style="margin-top: 0; margin-bottom: 0; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -1in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 1in"><b>Item 5.02</b></td><td><b>Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of
Certain Officers. </b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Transition of Edward Zecchini from the Board of Directors to Sr.
Vice President - Chief Digital &amp; Technology Officer of Cryoport, Inc.</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On February 10, 2024, Edward Zecchini accepted
the offer to join Cryoport, Inc. (the &#8220;Company&#8221;) as Senior Vice President &#8211; Chief Digital &amp; Technology Officer and
submitted his resignation from the Board of Directors of the Company both effective February 19, 2024. There were no disagreements between
Mr. Zecchini and the Company on any matter relating to the Company&#8217;s operations, policies or practices that led to his decision
to resign.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Amendments to Employment Agreements of Certain Officers</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As a result of a periodic review of employment contracts, the Company
took the following actions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On February 15, 2024, the Company entered into
an Amended and Restated Employment Agreement with Jerrell Shelton, President and Chief Executive Officer, which amended and restated his
current employment agreement (as previously amended) with the Company primarily to, among other things, (i) in the event he is terminated
without cause, remove his right to reimbursement for COBRA premiums and provide for full vesting of unvested equity awards, (ii) to extend
the term of the agreement to February 15, 2027, with automatic annual renewals thereafter unless his employment has earlier terminated
or either party provides not less than 180 days&#8217; notice of his or its intention not to renew, and (iii) provide that the expiration
of the agreement as a result of the non-renewal of the agreement by the Company is deemed to be termination without cause pursuant to
the terms of the agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On February 15, 2024, the Company entered into
an Amended and Restated Employment Agreement with Robert Stefanovich, Chief Financial Officer, which amended and restated his current
employment agreement (as previously amended) with the Company primarily to, among other things, (i) in the event he is terminated without
cause, reduce his right to reimbursement for COBRA premiums to the proportion of the COBRA premium equal to the same proportion that the
Company pays for active employees and their eligible dependents and provide for one year accelerated vesting of unvested equity awards,
(ii) to extend the term of the agreement to February 15, 2027, with automatic annual renewals thereafter unless his employment has earlier
terminated or either party provides not less than 180 days&#8217; notice of his or its intention not to renew, and (iii) provide that
the expiration of the agreement as a result of the non-renewal of the agreement by the Company is deemed to be termination without cause
pursuant to the terms of the agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On February 15, 2024, the Company entered into
an Amended and Restated Employment Agreement with Mark Sawicki, Chief Scientific Officer and Chief Executive Officer of Cryoport Systems,
LLC, a subsidiary of the Company, which amended and restated his current employment agreement (as previously amended) with the Company
primarily to, among other things, (i) in the event he is terminated without cause, reduce his right to reimbursement for COBRA premiums
to the proportion of the COBRA premium equal to the same proportion that the Company pays for active employees and their eligible dependents
and provide for one year accelerated vesting of unvested equity awards, (ii) to extend the term of the agreement to February 15, 2027,
with automatic annual renewals thereafter unless his employment has earlier terminated or either party provides not less than 180 days&#8217;
notice of his or its intention not to renew, and (iii) provide that the expiration of the agreement as a result of the non-renewal of
the agreement by the Company is deemed to be termination without cause pursuant to the terms of the agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The foregoing descriptions of the amended and
restated employment agreements of Mr. Shelton, Mr. Stefanovich, and Mr. Sawicki are each qualified in their entirety by reference to
the full text of the applicable agreement, which are filed as Exhibits 10.1, 10.2, and 10.3, respectively, to this Current Report on
Form 8-K and are incorporated by reference herein.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 1in"><b>Item 8.01</b></td><td><b>Other Events</b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The information relating to Mr. Zecchini joining
the Company as Senior Vice President &#8211; Chief Digital &amp; Technology Officer is incorporated by reference into this Item 8.01.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 96px; text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item 9.01</b></span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Financial Statements and Exhibits</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</span></td>
    <td style="width: 96px; text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibits.</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following material is filed as an exhibit to this Current Report on Form 8-K:</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;<b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top; text-align: left">
  <td style="text-align: left; width: 5%; vertical-align: bottom"><p style="margin-top: 0; margin-bottom: 0"><b>Exhibit</b></p>
                        <p style="margin-top: 0; margin-bottom: 0"><b><span style="text-decoration: underline">Number</span></b></p></td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 94%">&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="text-align: center; vertical-align: bottom"><a href="tm246433d1_ex10-1.htm">10.1</a></td>
  <td>&#160;</td>
  <td><a href="tm246433d1_ex10-1.htm">Amended and Restated Employment Agreement dated February 15, 2024 between Cryoport, Inc. and Jerrell W. Shelton.</a></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="text-align: center; vertical-align: bottom">&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="text-align: center; vertical-align: bottom"><a href="tm246433d1_ex10-2.htm">10.2</a></td>
  <td>&#160;</td>
  <td><a href="tm246433d1_ex10-2.htm">Amended and Restated Employment Agreement dated February 15, 2024 between Cryoport, Inc. and Robert S. Stefanovich.</a></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="text-align: center; vertical-align: bottom">&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="text-align: center; vertical-align: bottom"><a href="tm246433d1_ex10-3.htm">10.3</a></td>
  <td>&#160;</td>
  <td><a href="tm246433d1_ex10-3.htm">Amended and Restated Employment Agreement dated February 15, 2024 between Cryoport, Inc. and Mark Sawicki.</a></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="text-align: center; vertical-align: bottom">&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="text-align: center; vertical-align: bottom">104</td>
  <td>&#160;</td>
  <td>Cover
page interactive data file (embedded within the inline XBRL document).</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>


<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>SIGNATURES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.5pt; text-align: center; text-indent: -49.5pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top; text-align: left">
  <td style="width: 50%">Date: February 15, 2024</td>
  <td style="width: 50%">Cryoport, Inc.</td>
  </tr>
<tr style="vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td>&#160;</td>
  </tr>
<tr style="vertical-align: top; text-align: left">
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">/s/ Robert Stefanovich</td>
  </tr>
<tr style="vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td>Robert Stefanovich</td>
  </tr>
<tr style="vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td>Chief Financial Officer</td>
  </tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.5pt; text-align: center; text-indent: -49.5pt"><b>&#160;</b>&#160;</p>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.5pt; text-align: center"></p>

</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>tm246433d1_ex10-1.htm
<DESCRIPTION>EXHBIIT 10.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><B>Exhibit 10.1</B></P>

<P STYLE="margin: 0; text-align: left"><B>&nbsp;</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">AMENDED AND RESTATED EMPLOYMENT AGREEMENT</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Amended and Restated
Employment Agreement (the &ldquo;<B>Agreement</B>&rdquo;) is made and entered into effective as of February 15, 2024 (the &ldquo;<B>Effective
Date</B>&rdquo;) by and between Cryoport, Inc., a Nevada corporation (the &ldquo;<B>Company</B>&rdquo;), and Jerrell W. Shelton (&ldquo;<B>Executive</B>&rdquo;),
a resident of Tennessee. The Company and Executive are hereinafter collectively referred to as the &ldquo;<B>Parties</B>,&rdquo; and individually
referred to as a &ldquo;<B>Party</B>.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">RECITALS</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Parties entered into that certain Employment Agreement effective as of June 1, 2017 between the Company and Executive that was amended
by that certain First Amendment to Employment Agreement effective as of November 1, 2019 and that certain Second Amendment to Employment
Agreement effective as of March 15, 2024 (as amended, the &ldquo;<B>Prior Agreement</B>&rdquo;); and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">B.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company and Executive desire to enter into this Agreement to modify certain terms of the Prior Agreement by amending and restating such
agreement with the terms as set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">AGREEMENT</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>NOW</B>, <B>THEREFORE</B>,
in consideration of the mutual promises and covenants contained herein and for other good and valuable consideration, the receipt and
sufficiency of which are hereby acknowledged, the parties hereto agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>The Company hereby employs Executive, and Executive hereby accepts employment by the Company, upon the terms and conditions set
forth in this Agreement for the period beginning on the Effective Date. Executive shall be an at-will employee meaning that Executive&rsquo;s
Employment may be terminated by Executive or by Employer, for any reason or for no reason and with or without Cause (as defined below).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Executive shall serve as President and Chief Executive Officer of the Company, and shall have the normal duties, responsibilities
and authority of such office commensurate with the duties, authorities and responsibilities of persons in similar capacities in similarly
sized companies, unless otherwise determined from time to time by the Company&rsquo;s Board of Directors (the &ldquo;<B>Board</B>&rdquo;).
Executive shall do and perform all services, acts, or responsibilities necessary or advisable to carry out the duties of President and
Chief Executive Officer of the Company as assigned by the Company; provided, however, that at all times during his employment Executive
shall be subject to the direction and policies established from time to time by the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Executive agrees that if Executive&rsquo;s employment is terminated for any reason whatsoever, Executive will resign, at the Company&rsquo;s
request, from the Board and from any other positions Executive has as an officer or director of any of the Company&rsquo;s direct or indirect
subsidiaries and any other entity in which Executive is serving as an officer or director relating to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Loyal and Conscientious Performance</U></B>. During his employment with the Company, Executive shall devote sufficient energy,
abilities and productive time to the proper and efficient performance of this Agreement necessary to properly carry out the duties of
President and Chief Executive Officer. However, it is understood that Executive may serve on other boards of directors from time to time.
Executive agrees to notify the Board in writing upon acceptance of an appointment to a Board of Directors of another company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Compensation</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B>Base Salary</B>. The Company shall pay Executive an annual base salary in the amount determined by the Board (the &ldquo;<B>Base
Salary</B>&rdquo;), subject to standard payroll deductions and withholdings, and payable in accordance with the Company&rsquo;s normal
payroll practices. The Base Salary may be increased (but not reduced) periodically by the Compensation Committee of the Board (the &ldquo;<B>Compensation
Committee</B>&rdquo;). Notwithstanding the foregoing, the Base Salary may be reduced at the Company&rsquo;s discretion as part of a company-wide
austerity measure or a compliance initiative that applies uniformly to all senior executives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B>Incentive Compensation</B>. In addition to the Base Salary, Executive shall be eligible to participate in the Management Incentive
Plan (MIP) adopted by the Company from time to time in the amounts and at the times determined by the CEO and approved by the Compensation
Committee. If Executive terminates employment or is terminated by the Company for any reason other than for Cause (but including due to
death or disability) after the approval of MIP payout by the Compensation Committee and before such amount has been paid, then Executive
(or his estate, as applicable) shall be entitled to receive payment of any such earned MIP payout, as though he were still employed and
paid at the same time as other employed plan participants. Additionally, Executive is also eligible to participate in the Company equity
incentive program. Any stock options or other equity awards that Executive has previously been granted by the Company shall continue to
be governed in all respects by the terms of their applicable grant agreements, grant notices and plan documents. For the avoidance of
doubt, the MIP, the equity incentive program, and any other incentive compensation program implemented by the Company may be modified,
replaced or terminated in the future at the discretion of the Compensation Committee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B>Additional Benefits</B>. In addition to the Base Salary payable to Executive hereunder, Executive shall be entitled to the following
benefits:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Except as specifically provided herein, all benefits to which all other executive officers of the Company generally are entitled
as determined by the Board, on terms comparable thereto, including but not limited to, participation in any and all 401(k) plans, bonus
and incentive payment programs, group life insurance policies and plans, medical, health, dental and disability insurance policies and
plans, and the like, which may be maintained by the Company for the benefit of its executive officers, and which participation shall be
governed in all respects by the terms of the applicable benefit plan documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>During Executive&rsquo;s employment with the Company, Executive shall be entitled to paid vacation time in accordance with the
Company&rsquo;s normal and customary policies and procedures now in force or as such policies and procedures may be modified with respect
to senior executive officers of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>The Company shall reimburse Executive for all reasonable out-of-pocket business expenses incurred by him in the course of performing
his duties under this Agreement, which are consistent with the Company&rsquo;s policies in effect from time to time with respect to travel,
entertainment and other business expenses, subject to the Company&rsquo;s requirements with respect to reporting and documentation of
such expenses pursuant to Company policy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B>Withholding and Taxes</B>. All of Executive&rsquo;s compensation shall be subject to customary federal and state withholding
taxes and any other employment taxes as are commonly required to be collected or withheld by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Term</U></B>. The initial term of this Agreement shall be for a period beginning on the Effective Date and ending on the
third (3<SUP>rd</SUP>) anniversary of the Effective Date (the &ldquo;<B>Initial Term</B>&rdquo;) or, if earlier, the termination date
of Executive&rsquo;s employment in accordance with the provisions set forth in this Agreement. At the expiration (but not earlier termination)
of the Initial Term, and any subsequent Renewal Term (as defined below), the term of this Agreement shall automatically renew for additional
periods of one (1) year (each, a &ldquo;<B>Renewal Term</B>&rdquo;), unless Executive&rsquo;s employment has earlier terminated or either
party hereto has given the other party written notice of non-renewal at least one hundred and eighty (180) days prior to the expiration
date of the Initial Term or the Renewal Term, as applicable. If the Company gives Executive written notice of non-renewal, the expiration
of the Term or the Renewal Term (as applicable) shall be deemed to be the termination of Executive by the Company without Cause for all
purposes under this Agreement as of such date of expiration.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Early Termination</U></B>. This Agreement may be terminated early by the following means:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B>Termination for Cause</B>. The Company may terminate this Agreement for Cause (as defined herein) by delivering written notice
to Executive specifying the cause or causes relied upon for such termination. The termination will be effective immediately unless the
Company specifies a different date in the notice. If Executive&rsquo;s employment under this Agreement is terminated by the Company for
Cause, Executive&rsquo;s Base Salary shall immediately cease and Executive shall be entitled to: (i) Executive&rsquo;s earned and unpaid
Base Salary through the termination date; (ii) reimbursement for any reasonable accrued (but unpaid) expenses through the termination
date; (iii) any accrued but unused vacation time; and (iv) the vested employee benefits, if any, to which Executive is entitled pursuant
to the terms and conditions of the Company&rsquo;s benefit plans (the &ldquo;<B>Accrued Obligations</B>&rdquo;). Grounds for the Company
to terminate this Agreement for &ldquo;<B>Cause</B>&rdquo; shall include only the occurrence of any of the following events:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT> Executive&rsquo;s willful misconduct or gross negligence in the performance of his duties hereunder;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Executive&rsquo;s willful failure or refusal to perform in the usual manner at the usual time those duties which he regularly
and routinely performs in connection with the business of the Company or such other duties reasonably related to the capacity in which
he is employed hereunder which may be assigned to him by the Board or any act or omission that constitutes a material breach of this Agreement,
if such failure, refusal, or breach has not been substantially cured to the satisfaction of the Board within thirty (30) days after written
notice of such failure or refusal has been given by the Company to Executive;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT> Executive&rsquo;s performance of any action when specifically and reasonably instructed not to do so by the Board;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iv)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT> Executive&rsquo;s engaging or in any manner participating in any activity which is directly competitive with or intentionally
injurious to the Company (including, without limitation, Executive&rsquo;s violation of any Company policy involving harassment, discrimination,
intellectual property, confidentiality, non-competition, or non-solicitation);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(v)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT> Executive&rsquo;s commission of any fraud against the Company or use or appropriation for his personal use or benefit of any funds
or properties of the Company not authorized by the Board to be so used or appropriated; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(vi)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT> Executive&rsquo;s conviction of any crime involving moral turpitude, dishonesty, theft, fraud, or embezzlement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B>Termination Without Cause or For Good Reason</B>. The Company may voluntarily terminate this Agreement without Cause by giving
written notice to Executive. Any such notice shall specify the exact date of termination (the &ldquo;<B>Termination Date</B>&rdquo;).
Executive may voluntarily terminate this agreement for Good Reason by giving written notice to the Company specifying the exact Termination
Date. &ldquo;<B>Good Reason</B>&rdquo; means any of the following (i) a material diminution by the Company of Executive&rsquo;s then existing
base salary or non-equity incentive compensation opportunity, other than as contemplated by Section 3(a); (ii) a material diminution in
Executive&rsquo;s authorities, duties and/or responsibilities; or (iii) the Company&rsquo;s decision to permanently relocate Executive&rsquo;s
residence or the Company&rsquo;s principal business office by more than sixty (60) miles from its then current location and the Executive&rsquo;s
relocation with respect thereto; provided, however, that no termination by Executive shall constitute a termination for Good Reason unless:
(1) Executive gives the Company notice of the existence of the condition constituting Good Reason within thirty (30) days following the
initial occurrence thereof; (2) the Company does not remedy or cure the Good Reason condition within thirty (30) days of receiving such
notice described in (1); and (3) Executive terminates employment within thirty (30) days following the end of the cure period described
in (2). If Executive&rsquo;s employment under this Agreement is terminated by the Company without Cause or by Executive for Good Reason,
subject to the condition set forth below in Section 4(c), Executive shall be entitled to receive, after the Termination Date, the Accrued
Obligations and the following &ldquo;<B>Severance Benefits</B>&rdquo;: (i) twenty four (24) months of Executive&rsquo;s Base Salary at
the rate existing on the Termination Date; and (ii) all of the Awards (as defined in the Company&rsquo;s 2018 Omnibus Equity Incentive
Plan (&ldquo;<B>Plan</B>&rdquo;)) then held by Executive and not vested on the Termination Date shall become fully vested and exercisable
as of the Termination Date. All Base Salary payments shall be paid over time in accordance with the Company&rsquo;s general payroll practices,
as and when such Base Salary would have been paid had Executive&rsquo;s employment not terminated, with the first Base Salary installment
due for the payroll period beginning immediately following the expiration of the separation agreement revocation period described below.
Executive shall not be under any obligation to mitigate the Company&rsquo;s obligation by securing other employment or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B>Conditions to Receipt of Severance Benefits</B>. The receipt of the Severance Benefits in Section 4(b) will be subject to and
conditioned on Executive&rsquo;s signing and not revoking a separation agreement and release of claims in a form reasonably satisfactory
to the Company (the &ldquo;<B>Separation Agreement</B>&rdquo;) so that such Separation Agreement becomes effective no later than sixty
(60) days following Executive&rsquo;s Termination Date. Executive will have twenty-one (21) days to consider the Separation Agreement
and seven (7) days to revoke the Separation Agreement after signature on the Separation Agreement. For sake of clarity, no Severance Benefits
will be paid or provided until the Separation Agreement becomes effective. If any Severance Benefits under this Agreement (including the
Base Salary continuation) are not covered by one or more exemptions from the application of Section 409A of the Internal Revenue Code
of 1986, as amended (&ldquo;<B>Section 409A</B>&rdquo;) and the Separation Agreement could become effective in the calendar year following
the calendar year in which Executive&rsquo;s Termination Date occurs, then no Severance Benefits shall begin to be paid until the second
calendar year. Payments deferred pursuant to this Section shall be paid in a lump sum to Executive, and any remaining payments due shall
be paid as otherwise provided in Section 5(b), above. No interest shall be due on any amounts so deferred.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B>Termination by Executive</B>. Executive may voluntarily terminate this Agreement without Good Reason upon a ninety (90) day
written notice of such termination submitted to the Board, and in such event Executive shall only be entitled to receive the Accrued Obligations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT> <B>Termination upon Death or Disability</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>This Agreement shall terminate without notice upon the date of Executive&rsquo;s death or the date when Executive becomes &ldquo;completely
disabled&rdquo; as that term is defined in Section 4(e)(ii). In the event of Executive&rsquo;s death or compete disability, all rights
of Executive to compensation hereunder shall automatically terminate immediately upon his death or complete disability, except that Executive&rsquo;s
estate or Executive shall be entitled to the Accrued Obligations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>The term &ldquo;<B>completely disabled</B>&rdquo; as used in this Agreement shall mean the inability of Executive to perform his
duties under this Agreement because he has become permanently disabled within the meaning of any policy and disability income insurance
covering executives of the Company then in force. In the event the Company has no policy of disability income insurance covering executives
of the Company in force when Executive becomes disabled, the term &ldquo;completely disabled&rdquo; shall mean the inability of Executive
to perform his normal and customary duties under this Agreement for a total of four (4) consecutive months by reason of any incapacity,
physical or mental, based upon medical advice or an opinion provided by a licensed, American Board of Medical Specialties (ABMS) Board-Certified
physician acceptable to the Board. The action of the Board shall be final and binding and the date such action is taken shall be the date
of such complete disability for purposes of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Section 409A</U></B>. Notwithstanding anything set forth in this Agreement to the contrary, any payments and benefits provided
pursuant to this Agreement which constitute &ldquo;deferred compensation&rdquo; within the meaning of the Treasury Regulations issued
pursuant to Section 409A shall not commence until Executive has incurred a &ldquo;separation from service&rdquo; (as such term is defined
in the Treasury Regulation Section 1.409A-1(h) (&ldquo;<B>Separation From Service</B>&rdquo;), unless the Company reasonably determines
that such amounts may be provided to Executive without causing Executive to incur the additional twenty percent (20%) tax under Section
409A. It is intended that all of the Severance Benefits and other payments payable under this Agreement satisfy, to the greatest extent
possible, the exemptions from the application of Section 409A provided under Treasury Regulations 1.409A-1(b)(4), 1.409A-1(b)(5) and 1.409A-1(b)(9),
and this Agreement will be construed to the greatest extent possible as consistent with those provisions, and to the extent not so exempt,
this Agreement (and any definitions hereunder) will be construed in a manner that complies with Section 409A. Nevertheless, the Company
does not and cannot guarantee any particular tax effect or treatment of the amounts due under this Agreement. Except for the Company&rsquo;s
responsibility to withhold applicable income and employment taxes from compensation paid or provided to Executive, the Company will not
be responsible for the payment of any applicable taxes on compensation paid or provided pursuant to this Agreement. For purposes of Section
409A (including, without limitation, for purposes of Treasury Regulation Section 1.409A-2(b)(2)(iii)), Executive&rsquo;s right to receive
any installment payments under this Agreement (whether Severance Payments, reimbursements or otherwise) shall be treated as a right to
receive a series of separate and distinct payments. Notwithstanding any provision to the contrary in this Agreement, if Executive is deemed
by the Company at the time of Executive&rsquo;s Separation from Service to be a &ldquo;specified employee&rdquo; for purposes of Code
Section 409A(a)(2)(B)(i), and if any of the payments upon Separation from Service set forth herein and/or under any other agreement with
the Company are deemed to be &ldquo;deferred compensation,&rdquo; then to the extent delayed commencement of any portion of such payments
is required in order to avoid causing Executive to incur the additional twenty percent (20%) tax under Section 409A, such payments shall
not be provided to Executive prior to the earliest of (i) the first business day of the seventh (7<SUP>th</SUP>) month following Executive&rsquo;s
Separation from Service with the Company, (ii) the date of Executive&rsquo;s death, or (iii) such earlier date as permitted under Section
409A without the imposition of adverse taxation. All payments deferred pursuant to this Section shall be paid in a lump sum to Executive
on the first business day of the seventh (7<SUP>th</SUP>) month following Executive&rsquo;s Separation from Service, and any remaining
payments due shall be paid as otherwise provided in Section 5(b), above. No interest shall be due on any amounts so deferred. Notwithstanding
any other provision of this Agreement to the contrary, neither the time nor schedule of any payment under this Agreement may be accelerated
or subject to further deferral except as permitted by Section 409A. Executive does not have any right to make any election regarding the
time or form of any payment due under this Agreement. Any expenses that are to be reimbursed pursuant to this Agreement that are subject
to Section 409A shall: (i) be paid no later than the last day of Executive&rsquo;s tax year following the tax year in which the expense
was incurred; (ii) not affect or be affected by any other expenses that are eligible for reimbursement in any other tax year of Executive;
and (iii) not be subject to liquidation or exchange for any other benefit.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">7.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Non-Solicitation</U></B>. Executive agrees that during the period of his employment with the Company and for eighteen (18)
months after the date Executive&rsquo;s employment is terminated for any reason, Executive will not, either directly or through others,
solicit or encourage or attempt to solicit or encourage any employee, independent contractor, or consultant of the Company to terminate
his or her relationship with the Company in order to become an employee, consultant or independent contractor to or for any other person
or entity. This Section survives the termination of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">8.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Compensation Recovery</U></B>. By signing this Agreement, Executive agrees to be bound by, and comply with the terms of the
compensation recovery policy or policies (and related practices) of the Company or its affiliates as such may be in effect from time-to-time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">9.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Trade Secrets, Confidential Information and Inventions</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B>Trade Secrets in General</B>. During the course of Executive&rsquo;s employment, Executive will have access to various trade
secrets, confidential information and inventions of the Company as defined below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>&ldquo;<B>Confidential Information</B>&rdquo; means all information and material which is proprietary to the Company or any former,
present, or future parent, subsidiary, affiliate, successor, or assign of Company, whether or not marked as &ldquo;confidential&rdquo;
or &ldquo;proprietary&rdquo; and which is disclosed to or obtained from the Company by Executive or developed, created, or discovered
by Executive in his official capacity with the Company, which relates to the Company&rsquo;s past, present or future research, development
or business activities. Confidential Information is all information or materials prepared by or for the Company which information or materials
has commercial value in the business in which the Company is engaged and includes, without limitation, all of the following: designs,
drawings, specifications, techniques, models, data, source code, object code, documentation, diagrams, flow charts, research, development,
processes, systems, methods, machinery, procedures, &ldquo;know-how&rdquo;, new product or new technology information, formulas, patents,
patent applications, product prototypes, product copies, copyrights, possible transactions with other companies, actual or potential mergers
and acquisitions, equity issuances, cost of production, manufacturing, developing or marketing techniques and materials, cost of production,
development or marketing time tables, customer lists, strategies related to customers, suppliers or personnel, contract forms, pricing
policies and financial information, volumes of sales, and other information of similar nature, whether or not reduced to writing or other
tangible form, and any other Trade Secrets, as defined by subparagraph (iii), or non-public business information. Confidential Information
does not include any information which (1) was in the lawful and unrestricted possession of Executive prior to its disclosure by the Company,
(2) is or becomes generally available to the public by acts other than those of Executive (or anyone acting on his behalf) after receiving
it, (3) becomes generally available to the public by acts of Executive necessary to performing duties associated with their job description,
or (4) has been received lawfully and in good faith by Executive from a third party who did not derive it from the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>&ldquo;<B>Inventions</B>&rdquo; means all discoveries, concepts and ideas, whether patentable or not, including but not limited
to, processes, methods, formulas, compositions, techniques, articles and machines, as well as improvements and derivative works thereof
or &ldquo;know-how&rdquo; related thereto, relating at the time of conception or reduction to practice to the business engaged in by the
Company, or any actual or anticipated research or development by the Company. Inventions do not include any subject matter which qualifies
fully under the provisions of California Labor Code Section 2870, including any idea or invention which is developed entirely on Executive&rsquo;s
own time without using the Company&rsquo;s equipment, supplies, facilities, or Trade Secret information, and which is not related to the
Company&rsquo;s business, or actual or demonstrably anticipated research or development of the Company, and which does not result from
any work performed by Executive for the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>&ldquo;<B>Trade Secrets</B>&rdquo; shall mean any scientific, technical, or other data, information, design, process, procedure,
formula or improvement that is commercially available to the Company, that is not generally known in the industry, and that derives independent
economic value, actual or potential, from not being generally known to or readily ascertainable through appropriate means by other persons
who might obtain economic value from its disclosure or use.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Section includes not
only information belonging to the Company which existed before the date of this Agreement, but also information developed by Executive
for the Company or its employees during his employment and thereafter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B>Restriction on Use of Confidential Information</B>. Executive agrees that his use of Trade Secrets and other Confidential Information
is subject to the following restrictions during the term of the Agreement and for an indefinite period thereafter so long as the Trade
Secrets and other Confidential Information have not become generally known to the public.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B>Non-Disclosure</B>. Except as required by the performance of Executive&rsquo;s services to the Company under the terms of this
Agreement, neither Executive nor any of his agents or representatives, shall, directly or indirectly, publish or otherwise disclose, or
permit others to publish, divulge, disseminate, copy or otherwise disclose the Company&rsquo;s Trade Secrets, Confidential Information
and/or Inventions during or after the term of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B>Use Restriction</B>. Executive shall use the Trade Secrets, other Confidential Information and/or Inventions only for the limited
purpose for which they were disclosed. Executive shall not disclose the Trade Secrets, other Confidential Information and/or Inventions
to any third party without first obtaining written consent from the Board and shall disclose the Trade Secrets, other Confidential Information
and/or Inventions only to the Company&rsquo;s own employees having a need to know. Executive shall promptly notify the Board of any items
of Trade Secrets prematurely disclosed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B>Surrender Upon Termination</B>. Upon termination of his employment with the Company for any reason, Executive will surrender
and return to the Company all documents and materials in his possession or control which contain Trade Secrets, Inventions and other Confidential
Information. Executive shall immediately return to the Company all lists, books, records, materials and documents, together with all copies
thereof, and all other Company property in his possession or under his control, relating to or used in connection with the past, present
or anticipated business of the Company, or any affiliate or subsidiary thereof. Executive acknowledges and agrees that all such lists,
books, records, materials and documents, are the sole and exclusive property of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B>Prohibition Against Unfair Competition</B>. At any time after the termination of his employment with the Company for any reason,
Executive will not engage in competition with the Company while making use of the Trade Secrets of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(g)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B>Patents and Inventions</B>. Executive agrees that any inventions made, conceived or completed by him during the term of his
service, solely or jointly with others, which are made with the Company&rsquo;s equipment, supplies, facilities or Confidential Information,
or which relate at the time of conception or reduction to purpose of the Invention to the business of the Company or the Company&rsquo;s
actual or demonstrably anticipated research and development, or which result from any work performed by Executive for the Company, shall
be the sole and exclusive property of the Company. Executive promises to assign such inventions to the Company. Executive also agrees
that the Company shall have the right to keep such inventions as Trade Secrets, if the Company chooses. Executive agrees to assign to
the Company Executive&rsquo;s rights in any other inventions where the Company is required to grant those rights to the United States
government or any agency thereof. In order to permit the Company to claim rights to which it may be entitled, Executive agrees to disclose
to the Company in confidence all inventions which Executive makes arising out of Executive&rsquo;s service and all patent applications
filed by Executive within one year after the termination of his service. Executive shall assist the Company in obtaining patents on all
inventions, designs, improvements and discoveries patentable by the Company in the United States and in all foreign countries, and shall
execute all documents and do all things necessary to obtain letters patent, to vest the Company with full and extensive title thereto
during and after the term of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(h)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B>Government Agency Exception. </B>Nothing in this Agreement precludes Executive from filing a charge or complaint with, or participating
in any investigation or proceeding before, or reporting possible violations to, the Equal Employment Opportunity Commission (&ldquo;<U>EEOC</U>&rdquo;),
the National Labor Relations Board (&ldquo;<U>NLRB</U>&rdquo;), the Occupational Safety and Health Administration (&ldquo;<U>OSHA</U>&rdquo;),
the Securities and Exchange Commission (&ldquo;<U>SEC</U>&rdquo;), or any other federal, state or local governmental agency or commission
(&ldquo;<U>Government Agencies</U>&rdquo;).&nbsp; Executive further understands that this Agreement does not limit Executive&rsquo;s ability
to communicate with the Government Agencies or otherwise participate in any investigation or proceeding that may be conducted by any Government
Agency, including providing documents or other information, without notice to the Company, or prohibit Executive from participating in
activities that are protected under whistleblower provisions of federal law or regulation.&nbsp; This Agreement does not limit Executive&rsquo;s
right to receive an award for information provided to the SEC under SEC Rule 21F-17. Executive also confirms that he understands that
nothing in this Agreement prohibits him from reporting to any governmental authority information concerning possible violations of law
or regulation and that Executive may disclose trade secret information to a government official or to an attorney and use it in certain
court proceedings without fear of prosecution or liability provided Executive does so consistent with 18 U.S.C. 1833(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B>Cooperation</B>. Following the termination of Executive&rsquo;s employment for any reason, Executive will cooperate fully with
the Company and with the Company&rsquo;s counsel in connection with any present and future actual or threatened litigation, administrative
proceeding or other investigation involving the Company that relates to events, occurrences or conduct occurring (or claimed to have occurred)
during the term of Executive&rsquo;s employment with the Company. Expenses incurred by Executive, as related to any such requirement,
will be re-imbursed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(j)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B>Non-Disparagement; Social Media</B>. Executive will not criticize, defame, be derogatory toward or otherwise disparage the Company,
its products, services, or the Company&rsquo;s past, present and future officers, directors, managers, stockholders, members, attorneys,
agents, representatives, employees, or affiliates, or its or their business plans or actions, to any third party, either orally or in
writing; provided, however, that this provision will not preclude Executive from giving truthful testimony in response to a lawful subpoena
or preclude any conduct protected under any state or federal law providing &ldquo;whistleblower&rdquo; protection to Executive. In addition,
on the date of Executive&rsquo;s termination of employment, Executive shall update his profile on social media websites (such as LinkedIn)
to reflect that he is no longer an employee of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(k)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B>Survival</B>. This Section 9 survives the termination of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">10.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Miscellaneous</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B>Assignment and Binding Effect</B>. This Agreement shall be binding upon and inure to the benefit of Executive and Executive&rsquo;s
heirs, executors, administrators, estate, beneficiaries, and legal representatives. Neither this Agreement nor any rights or obligations
under this Agreement shall be assignable by either party without the prior express written consent of the other party. This Agreement
shall be binding upon and inure to the benefit of the Company and its successors, assigns and legal representatives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B>Notices</B>. All notices or demands of any kind required or permitted to be given by the Company or Executive under this Agreement
shall be given in writing and shall be personally delivered (and receipted for), or sent by recognized commercial overnight courier, or
mailed by certified mail, return receipt requested, postage prepaid, addressed as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If to the Company:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Corporate Secretary<BR>
Cryoport, Inc.<BR>
112 Westwood Place, Suite 350,<BR>
Brentwood, TN 37027</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If to Executive, to the Executive&rsquo;s
current address on file with the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Any such written notice shall
be deemed received when personally delivered or upon receipt in the event of overnight courier, or three (3) days after its deposit in
the United States mail by certified mail as specified above. Either Party may change its address for notices by giving notice to the other
Party in the manner specified in this Section.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B>Choice of Law; Arbitration</B>. This Agreement shall be construed and interpreted in accordance with the internal laws of the
State of Tennessee. The Parties agree that any controversy or claim arising out or relating to this Agreement, or the breach hereof, or
arising out of or relating to the employment of Executive and/or the rights, duties or obligations of the Company or of Executive shall
be settled by binding arbitration in accordance with the Arbitration Agreement in the form and substance attached as <U>Exhibit A</U>
and incorporated by this reference as though fully set forth herein. Executive agrees that Executive&rsquo;s signature on this Agreement
also serves as his signature to <U>Exhibit A</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B>Integration</B>. This Agreement contains the entire agreement of the parties relating to the subject matter of this Agreement,
except the Arbitration Agreement which is incorporated herein as provided in Section 10(c) and attached as <U>Exhibit A</U>, and supersedes
all prior oral and written employment agreements or arrangements between the Parties, including the Prior Agreement; <U>provided</U>,
that except as otherwise expressly stated in this Agreement, incentive awards granted to Executive shall be governed by the relevant plan
and any other related grant or award agreement and any other related documents. This Agreement cannot be amended or modified except by
a written agreement signed by Executive and the Company as approved by the Compensation Committee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B>Waiver</B>. No term, covenant or condition of this Agreement or any breach thereof shall be deemed waived, except with the written
consent of the Party against whom the waiver is claimed, and any waiver of any such term, covenant, condition or breach shall not be deemed
to be a waiver of any preceding or succeeding breach of the same or any other term, covenant, condition or breach. No failure to exercise,
delay in exercising, or single or partial exercise of any right, power or remedy by either party hereto shall constitute a waiver thereof
or shall preclude any other or further exercise of the same or any other right, power or remedy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B>Severability</B>. The unenforceability, invalidity, or illegality of any provision of this Agreement shall not render any other
provision of this Agreement unenforceable, invalid or illegal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(g)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B>Interpretation; Construction</B>. The headings set forth in this Agreement are for convenience only and shall not be used in
interpreting this Agreement. The Parties acknowledge that each Party and its counsel have reviewed and revised, or had an opportunity
to review and revise, this Agreement, and the normal rule of construction to the effect any ambiguities are to be resolved against the
drafting party shall not be employed in the interpretation of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(h)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B>Injunctive Relief</B>. In the event that Executive breaches any restrictive covenant, the Company shall be entitled to an injunction
restraining Executive from violating such restrictive covenant (without posting any bond or other security). The Parties agree that the
Arbitration Agreement in <U>Exhibit A</U> shall not preclude either Party from seeking temporary injunctive relief relating to the post-employment
restrictive covenants from a court of appropriate jurisdiction (with the matter then proceeding to arbitration after resolution of the
temporary injunction request). If the Company institutes any action or proceeding to enforce any such restrictive covenant, Executive
hereby waives the claim or defense that the Company has an adequate remedy at law and agrees not to assert in any such action or proceeding
the claim or defense that the Company has an adequate remedy at law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B>Attorneys&rsquo; Fees</B>. In any controversy or claim arising out of or relating to this Agreement or the breach thereof, which
results in legal action, proceeding or arbitration, the prevailing party in such action, as determined by the court or arbitrator, shall
be entitled to recover reasonable attorneys&rsquo; fees and costs incurred in such action.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(j)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B>Counterparts</B>. This Agreement may be executed in any number of counterparts, each of which when so executed and delivered
shall together constitute an original thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(k)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B>Representations and Warranties</B>. Executive represents and warrants that he is not restricted or prohibited, contractually
or otherwise, from entering into and performing each of the terms and covenants contained in this Agreement, and that his execution and
performance of this Agreement will not violate or breach any other agreement between Executive and any other person or entity. Executive
affirms that he has no agreement with any other party that would preclude his compliance with any obligations under this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(l)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B>Preservation of Property</B>. Executive will exercise reasonable care, consistent with good business judgment to preserve in
good working order, subject to reasonable wear and tear from authorized usage, and to prevent loss of, any equipment, instruments or accessories
of the Company in his custody for the purpose of conducting the business of the Company. Upon request, Executive will promptly surrender
the same to the Company at the conclusion of his employment, or if not surrendered, Executive will account to the Company to its reasonable
satisfaction as to the present location of all such instruments or accessories and the business purpose for their placement at such location.
At the conclusion of Executive&rsquo;s employment with the Company, he agrees to return such instruments or accessories to the Company
or to account for same to the Company&rsquo;s reasonable satisfaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>IN WITNESS WHEREOF</B>,
the Parties have executed this Agreement as of the Effective Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">CRYOPORT, INC.</TD>
    <TD>&nbsp;</TD>
    <TD>EXECUTIVE:</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 6%">&nbsp;</TD>
    <TD STYLE="width: 44%">&nbsp;</TD>
    <TD STYLE="width: 10%">&nbsp;</TD>
    <TD STYLE="width: 40%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid">/s/Robert Stefanovich</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">/s/Jerrell Shelton</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Name:</TD>
    <TD>Robert Stefanovich</TD>
    <TD>&nbsp;</TD>
    <TD>Jerrell Shelton</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Title:</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Chief Financial Officer</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(At the direction of the Compensation Committee)</P></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<!-- Field: Page; Sequence: 12; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>tm246433d1_ex10-2.htm
<DESCRIPTION>EXHIBIT 10.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><B>Exhibit 10.2</B></P>

<P STYLE="margin: 0; text-align: left"><B>&nbsp;</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">AMENDED AND RESTATED EMPLOYMENT AGREEMENT</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Amended and Restated
Employment Agreement (the &ldquo;<B>Agreement</B>&rdquo;) is made and entered into effective as of February 15, 2024 (the &ldquo;<B>Effective
Date</B>&rdquo;) by and between Cryoport, Inc., a Nevada corporation (the &ldquo;<B>Company</B>&rdquo;), and Robert S. Stefanovich (&ldquo;<B>Executive</B>&rdquo;).
The Company and Executive are hereinafter collectively referred to as the &ldquo;<B>Parties</B>,&rdquo; and individually referred to as
a &ldquo;<B>Party</B>.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">RECITALS</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Parties entered into that certain Employment Agreement effective as of November 1, 2019 between the Company and Executive that was amended
by that certain First Amendment to Employment Agreement effective as of March 24, 2023 (the &ldquo;<B>Prior Agreement</B>&rdquo;); and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">B.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company and Executive desire to enter into this Agreement to modify certain terms of the Prior Agreement by amending and restating such
agreement with the terms as set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">AGREEMENT</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>NOW</B>, <B>THEREFORE</B>,
in consideration of the mutual promises and covenants contained herein and for other good and valuable consideration, the receipt and
sufficiency of which are hereby acknowledged, the parties hereto agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Employment</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>The Company hereby employs Executive, and Executive hereby accepts employment by the Company, upon the terms and conditions set
forth in this Agreement for the period beginning on the Effective Date. Executive shall be an at-will employee meaning that Executive&rsquo;s
Employment may be terminated by Executive or by Employer, for any reason or for no reason and with or without Cause (as defined below).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Executive shall serve as Senior Vice President, Chief Financial Officer and Treasurer of the Company and shall have the normal
duties, responsibilities, and authority of such office commensurate with the duties, authorities, and responsibilities of persons in similar
capacities in similarly sized companies, unless otherwise determined from time-to-time by the Company&rsquo;s Chief Executive Officer
(&ldquo;<B>CEO</B>&rdquo;). Executive shall do and perform all services, acts, or responsibilities necessary or advisable to carry out
the duties of Senior Vice President, Chief Financial Officer and Treasurer of the Company, as assigned by the Company; provided, however,
that at all times during his employment Executive shall be subject to the direction and/or policies established from time to time by the
CEO.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Executive agrees that if Executive&rsquo;s employment is terminated for any reason whatsoever, Executive will resign, at the Company&rsquo;s
request, from any positions Executive has as an officer or director of the Company and of any of the Company&rsquo;s direct or indirect
subsidiaries and any other entity in which Executive is serving as an officer or director relating to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Loyal and Conscientious Performance</U></B>. During his employment with the Company, Executive shall devote sufficient energy,
abilities, and productive time to the proper and efficient performance of this Agreement necessary to properly carry out the duties of
Senior Vice President, Chief Financial Officer and Treasurer of the Company. Executive may serve on the board of directors of one other
company with the prior approval of the CEO.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Compensation</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B>Base Salary</B>. The Company shall pay Executive an annual base salary in the amount as determined by the CEO and recommended
to the Board by the CEO and approved by the Compensation Committee of the Board of the Company (the &ldquo;<B>Compensation Committee</B>&rdquo;
and the &ldquo;<B>Base Salary</B>&rdquo;), subject to standard payroll deductions and withholdings, and payable in accordance with the
Company&rsquo;s normal payroll practices. Notwithstanding the foregoing, the Base Salary may be reduced at the Company&rsquo;s discretion
as part of a company-wide austerity measure or a compliance initiative that applies uniformly to all senior executives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B>Incentive Compensation</B>. In addition to the Base Salary, Executive shall be eligible to participate in the Management Incentive
Plan (MIP) adopted by the Company from time to time in the amounts and at the times determined by the CEO and approved by the Compensation
Committee. Additionally, Executive is also eligible to participate in the Company equity incentive program. Any stock options or other
equity awards that Executive has previously been granted by the Company shall continue to be governed in all respects by the terms of
their applicable grant agreements, grant notices and plan documents. For the avoidance of doubt, the MIP, the equity incentive program,
and any other incentive compensation program implemented by the Company may be modified, replaced, or terminated in the future at the
discretion of the Compensation Committee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B>Additional Benefits</B>. In addition to the Base Salary payable to Executive hereunder, Executive shall be entitled to the following
benefits:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Except as specifically provided herein, all benefits to which all other executive officers of the Company generally are entitled
as determined by the Board, on terms comparable thereto, including but not limited to, participation in any and all 401(k) plans, bonus
and incentive payment programs, group life insurance policies and plans, medical, health, dental and disability insurance policies and
plans, and the like, which may be maintained by the Company for the benefit of its executive officers, and which participation shall be
governed in all respects by the terms of the applicable benefit plan documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>During Executive&rsquo;s employment with the Company, Executive shall be entitled to paid vacation time in accordance with the
Company&rsquo;s normal and customary policies and procedures now in force or as such policies and procedures may be modified with respect
to senior executive officers of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>The Company shall reimburse Executive for all reasonable out-of-pocket business expenses incurred by him in the course of performing
his duties under this Agreement, which are consistent with the Company&rsquo;s policies in effect from time to time with respect to travel,
entertainment and other business expenses, subject to the Company&rsquo;s requirements with respect to reporting and documentation of
such expenses pursuant to Company policy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B>Withholding and Taxes</B>. All of Executive&rsquo;s compensation shall be subject to customary federal and state withholding
taxes and any other employment taxes as are commonly required to be collected or withheld by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Term</U></B>.<FONT STYLE="background-color: white">&nbsp; The initial term of this Agreement shall be for a period beginning
on the Effective Date and ending on the third (3<SUP>rd</SUP>) anniversary of the Effective Date (the &ldquo;<B>Initial Term</B>&rdquo;)
or, if earlier, the termination date of Executive&rsquo;s employment in accordance with the provisions set forth in this Agreement. At
the expiration (but not earlier termination) of the Initial Term, and any subsequent Renewal Term (as defined below), the term of this
Agreement shall automatically renew for additional periods of one (1) year (each, a &ldquo;<B>Renewal Term</B>&rdquo;), unless Executive&rsquo;s
employment has earlier terminated or either party hereto has given the other party written notice of non-renewal at least one hundred
and eighty (180) days prior to the expiration date of the Initial Term or the Renewal Term, as applicable. If the Company gives Executive
written notice of non-renewal, the expiration of the Term or the Renewal Term (as applicable) shall be deemed to be the termination of
Executive by the Company without Cause for all purposes under this Agreement as of such date of expiration.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Early Termination</U></B>. This Agreement may be terminated early by the following means:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B>Termination for Cause</B>. The Company may terminate this Agreement for Cause (as defined herein) by delivering written notice
to Executive specifying the cause or causes relied upon for such termination. The termination will be effective immediately unless the
Company specifies a different date in the notice. If Executive&rsquo;s employment under this Agreement is terminated by the Company for
Cause, Executive&rsquo;s Base Salary shall immediately cease and Executive shall be entitled to: (i) Executive&rsquo;s earned and unpaid
Base Salary through the termination date; (ii) reimbursement for any reasonable accrued (but unpaid) expenses through the termination
date; (iii) any accrued but unused vacation time; and (iv) the vested employee benefits, if any, to which Executive is entitled pursuant
to the terms and conditions of the Company&rsquo;s benefit plans (the &ldquo;<B>Accrued Obligations</B>&rdquo;). Grounds for the Company
to terminate this Agreement for &ldquo;<B>Cause</B>&rdquo; shall include only the occurrence of any of the following events:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT> Executive&rsquo;s willful misconduct or gross negligence in the performance of his duties hereunder;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT> Executive&rsquo;s willful failure or refusal to perform in the usual manner at the usual time those duties which he regularly
and routinely performs in connection with the business of the Company or such other duties reasonably related to the capacity in which
he is employed hereunder which may be assigned to him by the CEO or any act or omission that constitutes a material breach of this Agreement,
if such failure, refusal, or breach has not been substantially cured to the satisfaction of the CEO within thirty (30) days after written
notice of such failure or refusal has been given by the Company to Executive;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT> Executive&rsquo;s performance of any action when specifically and reasonably instructed not to do so by the CEO;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iv)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT> Executive&rsquo;s engaging or in any manner participating in any activity which is directly competitive with or intentionally
injurious to the Company (including, without limitation, Executive&rsquo;s violation of any Company policy involving harassment, discrimination,
intellectual property, confidentiality, non-competition, or non-solicitation);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(v)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT> Executive&rsquo;s commission of any fraud against the Company or use or appropriation for his personal use or benefit of any funds
or properties of the Company not authorized by the Board to be so used or appropriated; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(vi)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT> Executive&rsquo;s conviction of any crime involving moral turpitude, dishonesty, theft, fraud, or embezzlement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B>Termination Without Cause or For Good Reason</B>. The Company may voluntarily terminate this Agreement without Cause by giving
written notice to Executive. Any such notice shall specify the exact date of termination (the &ldquo;<B>Termination Date</B>&rdquo;).
Executive may voluntarily terminate this agreement for Good Reason by giving written notice to the Company specifying the exact Termination
Date. &ldquo;<B>Good Reason</B>&rdquo; means any of the following (i) a material diminution by the Company of Executive&rsquo;s then existing
base salary or non-equity incentive compensation opportunity, other than as contemplated by <U>Section 3(a)</U>; (ii) a material diminution
in Executive&rsquo;s authorities, duties and/or responsibilities; or (iii) the Company&rsquo;s decision to permanently relocate Executive&rsquo;s
residence or the Company&rsquo;s principal business office by more than sixty (60) miles from its then current location and the Executive&rsquo;s
relocation with respect thereto; provided, however, that no termination by Executive shall constitute a termination for Good Reason unless:
(1) Executive gives the Company notice of the existence of the condition constituting Good Reason within thirty (30) days following the
initial occurrence thereof; (2) the Company does not remedy or cure the Good Reason condition within thirty (30) days of receiving such
notice described in (1); and (3) Executive terminates employment within thirty (30) days following the end of the cure period described
in (2). If Executive&rsquo;s employment under this Agreement is terminated by the Company without Cause or by Executive for Good Reason,
subject to the condition set forth below in <U>Section 5(c)</U>, Executive shall be entitled to receive, after the Termination Date, the
Accrued Obligations and the following &ldquo;<B>Severance Benefits</B>&rdquo;: (i) eighteen (18) months of his Base Salary at the rate
existing on the Termination Date; (ii) if Executive timely elects continued coverage under the Consolidated Omnibus Budget Reconciliation
Act of 1985 (&ldquo;<B>COBRA</B>&rdquo;) or any state equivalent, for himself and his covered dependents under the Company&rsquo;s group
health plans following such termination, then the Company shall pay the same portion of the monthly premium under COBRA as it pays for
active employees and their eligible dependents&nbsp;from the Termination Date until the earliest of (A) the date that is eighteen (18)
months after the Termination Date, (B) the expiration of Executive&rsquo;s eligibility for continuation coverage under COBRA, or (C) the
date when Executive becomes eligible for substantially equivalent health insurance coverage in connection with new employment or self-employment
(such period from the termination date through the earliest of (A) through (C), the &ldquo;<B>COBRA Payment Period</B>&rdquo;); and (iii)
with respect to Awards (as defined in the Company&rsquo;s 2018 Omnibus Equity Incentive Plan then held by Executive and not vested as
of the Termination Date, accelerated vesting of such Awards such that Executive gets twelve (12) full months of vesting credit from the
Termination Date; provided that, if the Termination Date is in connection with or within twelve (12) months after a &ldquo;Change in Control&rdquo;
(as defined in the Plan), then all of the Awards then held by Executive and not vested at the time of such termination shall become fully
vested and exercisable as of the Termination Date. With respect to payment of COBRA premiums described above, Executive must pay his portion
of any premiums with after-tax income and any portion of such premiums paid for by the Company shall be fully taxable to Executive. If
Executive becomes eligible for coverage under another employer&rsquo;s group health plan, through self-employment, or otherwise ceases
to be eligible for COBRA coverage during the period provided in this Section, Executive must immediately notify the Company of such event,
and the Company&rsquo;s obligation to pay COBRA premiums on Executive&rsquo;s behalf shall cease. Notwithstanding the foregoing, if at
any time the Company determines, in its sole discretion, that its payment of COBRA premiums on Executive&rsquo;s behalf would result in
a violation of applicable law (including, without limitation, Section 2716 of the Public Health Service Act), then in lieu of paying COBRA
premiums on Executive&rsquo;s behalf, the Company will pay Executive on the last day of each remaining month of the COBRA Payment Period
a cash payment equal to the COBRA premium for that month, which payment shall be subject to applicable tax withholding (such amount, the
 &ldquo;<B>Special Severance Payment</B>&rdquo;), such Special Severance Payment to be made without regard to Executive&rsquo;s payment
of COBRA premiums and without regard to the expiration of the COBRA Payment Period prior to the end of the COBRA continuation period.
Such Special Severance Payment shall end on the earlier of (i)&nbsp;the date on which Executive commences other full-time, regular employment
(i.e., excluding temporary or consulting positions) and (ii) the close or termination of the COBRA continuation period following Executive&rsquo;s
termination. All Base Salary payments shall be paid over time in accordance with the Company&rsquo;s general payroll practices, as and
when such Base Salary would have been paid had Executive&rsquo;s employment not terminated, with the first Base Salary installment due
for the payroll period beginning immediately following the expiration of the separation agreement revocation period described below. Executive
shall not be under any obligation to mitigate the Company&rsquo;s obligation by securing other employment or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B>Conditions to Receipt of Severance Benefits</B>. The receipt of the Severance Benefits in <U>Section 5(b)</U> will be subject
to and conditioned on Executive&rsquo;s signing and not revoking a separation agreement and release of claims in a form reasonably satisfactory
to the Company (the &ldquo;<B>Separation Agreement</B>&rdquo;) so that such Separation Agreement becomes effective no later than forty-five
(45) days following Executive&rsquo;s Termination Date. Executive will have twenty-one (21) days to consider the Separation Agreement
and seven (7) days to revoke the Separation Agreement after signature on the Separation Agreement. For sake of clarity, no Severance Benefits
will be paid or provided until the Separation Agreement becomes effective. If any Severance Benefits under this Agreement (including the
Base Salary continuation) are not covered by one or more exemptions from the application of Section 409A of the Internal Revenue Code
of 1986, as amended (&ldquo;<B>Section 409A</B>&rdquo;) and the Separation Agreement could become effective in the calendar year following
the calendar year in which Executive&rsquo;s Termination Date occurs, then no Severance Benefits shall begin to be paid until the second
calendar year. Payments deferred pursuant to this Section shall be paid in a lump sum to Executive, and any remaining payments due shall
be paid as otherwise provided in Section 5(b), above. No interest shall be due on any amounts so deferred.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B>Termination by Executive</B>. Executive may voluntarily terminate this Agreement without Good Reason upon a ninety (90) day
written notice of such termination submitted to the CEO, and in such event, Executive shall only be entitled to receive the Accrued Obligations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT> <B>Termination upon Death or Disability</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>This Agreement shall terminate without notice upon the date of Executive&rsquo;s death or the date when Executive becomes &ldquo;completely
disabled&rdquo; as that term is defined in <U>Section 5(e)(ii)</U>. In the event of Executive&rsquo;s death or compete disability, all
rights of Executive to compensation hereunder shall automatically terminate immediately upon his death or complete disability, except
that Executive&rsquo;s estate or Executive shall be entitled to the Accrued Obligations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>The term &ldquo;<B>completely disabled</B>&rdquo; as used in this Agreement shall mean the inability of Executive to perform his
duties under this Agreement because he has become permanently disabled within the meaning of any policy and disability income insurance
covering executives of the Company then in force. In the event the Company has no policy of disability income insurance covering executives
of the Company in force when Executive becomes disabled, the term &ldquo;completely disabled&rdquo; shall mean the inability of Executive
to perform his normal and customary duties under this Agreement for a total of four (4) consecutive months by reason of any incapacity,
physical or mental, based upon medical advice or an opinion provided by a licensed, American Board of Medical Specialties (ABMS) Board-Certified
physician acceptable to the Board. The action of the Board shall be final and binding and the date such action is taken shall be the date
of such complete disability for purposes of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Section 409A</U></B>. Notwithstanding anything set forth in this Agreement to the contrary, any payments and benefits provided
pursuant to this Agreement which constitute &ldquo;deferred compensation&rdquo; within the meaning of the Treasury Regulations issued
pursuant to Section 409A shall not commence until Executive has incurred a &ldquo;separation from service&rdquo; (as such term is defined
in the Treasury Regulation Section 1.409A-1(h) (&ldquo;<B>Separation From Service</B>&rdquo;), unless the Company reasonably determines
that such amounts may be provided to Executive without causing Executive to incur the additional twenty percent (20%) tax under Section
409A. It is intended that all of the Severance Benefits and other payments payable under this Agreement satisfy, to the greatest extent
possible, the exemptions from the application of Section 409A provided under Treasury Regulations 1.409A-1(b)(4), 1.409A-1(b)(5) and 1.409A-1(b)(9),
and this Agreement will be construed to the greatest extent possible as consistent with those provisions, and to the extent not so exempt,
this Agreement (and any definitions hereunder) will be construed in a manner that complies with Section 409A. Nevertheless, the Company
does not and cannot guarantee any particular tax effect or treatment of the amounts due under this Agreement. Except for the Company&rsquo;s
responsibility to withhold applicable income and employment taxes from compensation paid or provided to Executive, the Company will not
be responsible for the payment of any applicable taxes on compensation paid or provided pursuant to this Agreement. For purposes of Section
409A (including, without limitation, for purposes of Treasury Regulation Section 1.409A-2(b)(2)(iii)), Executive&rsquo;s right to receive
any installment payments under this Agreement (whether Severance Payments, reimbursements or otherwise) shall be treated as a right to
receive a series of separate and distinct payments. Notwithstanding any provision to the contrary in this Agreement, if Executive is deemed
by the Company at the time of Executive&rsquo;s Separation from Service to be a &ldquo;specified employee&rdquo; for purposes of Code
Section 409A(a)(2)(B)(i), and if any of the payments upon Separation from Service set forth herein and/or under any other agreement with
the Company are deemed to be &ldquo;deferred compensation,&rdquo; then to the extent delayed commencement of any portion of such payments
is required in order to avoid causing Executive to incur the additional twenty percent (20%) tax under Section 409A, such payments shall
not be provided to Executive prior to the earliest of (i) the first business day of the seventh (7<SUP>th</SUP>) month following Executive&rsquo;s
Separation from Service with the Company, (ii) the date of Executive&rsquo;s death, or (iii) such earlier date as permitted under Section
409A without the imposition of adverse taxation. All payments deferred pursuant to this Section shall be paid in a lump sum to Executive
on the first business day of the seventh (7<SUP>th</SUP>) month following Executive&rsquo;s Separation from Service, and any remaining
payments due shall be paid as otherwise provided in Section 5(b), above. No interest shall be due on any amounts so deferred. Notwithstanding
any other provision of this Agreement to the contrary, neither the time nor schedule of any payment under this Agreement may be accelerated
or subject to further deferral except as permitted by Section 409A. Executive does not have any right to make any election regarding the
time or form of any payment due under this Agreement. Any expenses that are to be reimbursed pursuant to this Agreement that are subject
to Section 409A shall: (i) be paid no later than the last day of Executive&rsquo;s tax year following the tax year in which the expense
was incurred; (ii) not affect or be affected by any other expenses that are eligible for reimbursement in any other tax year of Executive;
and (iii) not be subject to liquidation or exchange for any other benefit.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">7.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Non-Solicitation</U></B>. Executive agrees that during the period of his employment with the Company and for eighteen (18)
months after the date Executive&rsquo;s employment is terminated for any reason, Executive will not, either directly or through others,
solicit or encourage or attempt to solicit or encourage any employee, independent contractor, or consultant of the Company to terminate
his or her relationship with the Company in order to become an employee, consultant or independent contractor to or for any other person
or entity. This Section survives the termination of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">8.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Compensation Recovery</U></B>. By signing this Agreement, Executive agrees to be bound by, and comply with the terms of the
compensation recovery policy or policies (and related practices) of the Company or its affiliates as such may be in effect from time-to-time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">9.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Trade Secrets, Confidential Information and Inventions</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B>Trade Secrets in General</B>. During the course of Executive&rsquo;s employment, Executive will have access to various trade
secrets, confidential information and inventions of the Company as defined below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>&ldquo;<B>Confidential Information</B>&rdquo; means all information and material which is proprietary to the Company or any former,
present, or future parent, subsidiary, affiliate, successor, or assign of Company, whether or not marked as &ldquo;confidential&rdquo;
or &ldquo;proprietary&rdquo; and which is disclosed to or obtained from the Company by Executive or developed, created, or discovered
by Executive in his official capacity with the Company, which relates to the Company&rsquo;s past, present or future research, development
or business activities. Confidential Information is all information or materials prepared by or for the Company which information or materials
has commercial value in the business in which the Company is engaged and includes, without limitation, all of the following: designs,
drawings, specifications, techniques, models, data, source code, object code, documentation, diagrams, flow charts, research, development,
processes, systems, methods, machinery, procedures, &ldquo;know-how&rdquo;, new product or new technology information, formulas, patents,
patent applications, product prototypes, product copies, copyrights, possible transactions with other companies, actual or potential mergers
and acquisitions, equity issuances, cost of production, manufacturing, developing or marketing techniques and materials, cost of production,
development or marketing time tables, customer lists, strategies related to customers, suppliers or personnel, contract forms, pricing
policies and financial information, volumes of sales, and other information of similar nature, whether or not reduced to writing or other
tangible form, and any other Trade Secrets, as defined by subparagraph (iii), or non-public business information. Confidential Information
does not include any information which (1) was in the lawful and unrestricted possession of Executive prior to its disclosure by the Company,
(2) is or becomes generally available to the public by acts other than those of Executive (or anyone acting on his behalf) after receiving
it, (3) becomes generally available to the public by acts of Executive necessary to performing duties associated with their job description,
or (4) has been received lawfully and in good faith by Executive from a third party who did not derive it from the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>&ldquo;<B>Inventions</B>&rdquo; means all discoveries, concepts, and ideas, whether patentable or not, including but not limited
to, processes, methods, formulas, compositions, techniques, articles and machines, as well as improvements and derivative works thereof
or &ldquo;know-how&rdquo; related thereto, relating at the time of conception or reduction to practice to the business engaged in by the
Company, or any actual or anticipated research or development by the Company. Inventions do not include any subject matter which qualifies
fully under the provisions of California Labor Code Section 2870, including any idea or invention which is developed entirely on Executive&rsquo;s
own time without using the Company&rsquo;s equipment, supplies, facilities, or Trade Secret information, and which is not related to the
Company&rsquo;s business, or actual or demonstrably anticipated research or development of the Company, and which does not result from
any work performed by Executive for the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>&ldquo;<B>Trade Secrets</B>&rdquo; shall mean any scientific, technical, or other data, information, design, process, procedure,
formula or improvement that is commercially available to the Company, that is not generally known in the industry, and that derives independent
economic value, actual or potential, from not being generally known to or readily ascertainable through appropriate means by other persons
who might obtain economic value from its disclosure or use.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Section includes not
only information belonging to the Company which existed before the date of this Agreement, but also information developed by Executive
for the Company or its employees during his employment and thereafter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B>Restriction on Use of Confidential Information</B>. Executive agrees that his use of Trade Secrets and other Confidential Information
is subject to the following restrictions during the term of the Agreement and for an indefinite period thereafter so long as the Trade
Secrets and other Confidential Information have not become generally known to the public.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B>Non-Disclosure</B>. Except as required by the performance of Executive&rsquo;s services to the Company under the terms of this
Agreement, neither Executive nor any of his agents or representatives, shall, directly or indirectly, publish or otherwise disclose, or
permit others to publish, divulge, disseminate, copy or otherwise disclose the Company&rsquo;s Trade Secrets, Confidential Information
and/or Inventions during or after the term of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B>Use Restriction</B>. Executive shall use the Trade Secrets, other Confidential Information and/or Inventions only for the limited
purpose for which they were disclosed. Executive shall not disclose the Trade Secrets, other Confidential Information and/or Inventions
to any third party without first obtaining written consent from the Board and shall disclose the Trade Secrets, other Confidential Information
and/or Inventions only to the Company&rsquo;s own employees having a need to know. Executive shall promptly notify the Board of any items
of Trade Secrets prematurely disclosed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B>Surrender Upon Termination</B>. Upon termination of his employment with the Company for any reason, Executive will surrender
and return to the Company all documents and materials in his possession or control which contain Trade Secrets, Inventions, and other
Confidential Information. Executive shall immediately return to the Company all lists, books, records, materials, and documents, together
with all copies thereof, and all other Company property in his possession or under his control, relating to or used in connection with
the past, present or anticipated business of the Company, or any affiliate or subsidiary thereof. Executive acknowledges and agrees that
all such lists, books, records, materials, and documents, are the sole and exclusive property of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B>Prohibition Against Unfair Competition</B>. At any time after the termination of his employment with the Company for any reason,
Executive will not engage in competition with the Company while making use of the Trade Secrets of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(g)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B>Patents and Inventions</B>. Executive agrees that any inventions made, conceived or completed by him during the term of his
service, solely or jointly with others, which are made with the Company&rsquo;s equipment, supplies, facilities or Confidential Information,
or which relate at the time of conception or reduction to purpose of the Invention to the business of the Company or the Company&rsquo;s
actual or demonstrably anticipated research and development, or which result from any work performed by Executive for the Company, shall
be the sole and exclusive property of the Company. Executive promises to assign such inventions to the Company. Executive also agrees
that the Company shall have the right to keep such inventions as Trade Secrets, if the Company chooses. Executive agrees to assign to
the Company Executive&rsquo;s rights in any other inventions where the Company is required to grant those rights to the United States
government or any agency thereof. In order to permit the Company to claim rights to which it may be entitled, Executive agrees to disclose
to the Company in confidence all inventions which Executive makes arising out of Executive&rsquo;s service and all patent applications
filed by Executive within one year after the termination of his service. Executive shall assist the Company in obtaining patents on all
inventions, designs, improvements and discoveries patentable by the Company in the United States and in all foreign countries and shall
execute all documents and do all things necessary to obtain letters patent, to vest the Company with full and extensive title thereto
during and after the term of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(h)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B>Government Agency Exception. </B>Nothing in this Agreement precludes Executive from filing a charge or complaint with, or participating
in any investigation or proceeding before, or reporting possible violations to, the Equal Employment Opportunity Commission (&ldquo;<U>EEOC</U>&rdquo;),
the National Labor Relations Board (&ldquo;<U>NLRB</U>&rdquo;), the Occupational Safety and Health Administration (&ldquo;<U>OSHA</U>&rdquo;),
the Securities and Exchange Commission (&ldquo;<U>SEC</U>&rdquo;), or any other federal, state or local governmental agency or commission
(&ldquo;<U>Government Agencies</U>&rdquo;).&nbsp; Executive further understands that this Agreement does not limit Executive&rsquo;s ability
to communicate with the Government Agencies or otherwise participate in any investigation or proceeding that may be conducted by any Government
Agency, including providing documents or other information, without notice to the Company, or prohibit Executive from participating in
activities that are protected under whistleblower provisions of federal law or regulation.&nbsp; This Agreement does not limit Executive&rsquo;s
right to receive an award for information provided to the SEC under SEC Rule 21F-17. Executive also confirms that he understands that
nothing in this Agreement prohibits him from reporting to any governmental authority information concerning possible violations of law
or regulation and that Executive may disclose trade secret information to a government official or to an attorney and use it in certain
court proceedings without fear of prosecution or liability provided Executive does so consistent with 18 U.S.C. 1833(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B>Cooperation</B>. Following the termination of Executive&rsquo;s employment for any reason, Executive will cooperate fully with
the Company and with the Company&rsquo;s counsel in connection with any present and future actual or threatened litigation, administrative
proceeding or other investigation involving the Company that relates to events, occurrences or conduct occurring (or claimed to have occurred)
during the term of Executive&rsquo;s employment with the Company. Expenses incurred by Executive, as related to any such requirement,
will be re-imbursed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(j)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B>Non-Disparagement; Social Media</B>. Executive will not criticize, defame, be derogatory toward or otherwise disparage the Company,
its products, services, or the Company&rsquo;s past, present and future officers, directors, managers, stockholders, members, attorneys,
agents, representatives, employees, or affiliates, or its or their business plans or actions, to any third party, either orally or in
writing; provided, however, that this provision will not preclude Executive from giving truthful testimony in response to a lawful subpoena
or preclude any conduct protected under any state or federal law providing &ldquo;whistleblower&rdquo; protection to Executive. In addition,
on the date of Executive&rsquo;s termination of employment, Executive shall update his profile on social media websites (such as LinkedIn)
to reflect that he is no longer an employee of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(k)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B>Survival</B>. This Section 9 survives the termination of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">10.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Miscellaneous</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B>Assignment and Binding Effect</B>. This Agreement shall be binding upon and inure to the benefit of Executive and Executive&rsquo;s
heirs, executors, administrators, estate, beneficiaries, and legal representatives. Neither this Agreement nor any rights or obligations
under this Agreement shall be assignable by either party without the prior express written consent of the other party. This Agreement
shall be binding upon and inure to the benefit of the Company and its successors, assigns and legal representatives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B>Notices</B>. All notices or demands of any kind required or permitted to be given by the Company or Executive under this Agreement
shall be given in writing and shall be personally delivered (and receipted for), or sent by recognized commercial overnight courier, or
mailed by certified mail, return receipt requested, postage prepaid, addressed as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If to the Company:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Corporate Secretary</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Cryoport, Inc.<BR>
112 Westwood Place, Suite 350</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Brentwood, TN 37027</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If to Executive, to the then-current
address on file with the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Any such written notice shall
be deemed received when personally delivered or upon receipt in the event of overnight courier, or three (3) days after its deposit in
the United States mail by certified mail as specified above. Either Party may change its address for notices by giving notice to the other
Party in the manner specified in this Section.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B>Choice of Law; Arbitration</B>. This Agreement shall be construed and interpreted in accordance with the internal laws of the
State of Tennessee. The Parties agree that any controversy or claim arising out or relating to this Agreement, or the breach hereof, or
arising out of or relating to the employment of Executive and/or the rights, duties or obligations of the Company or of Executive shall
be settled by binding arbitration in accordance with the Arbitration Agreement in the form and substance attached as <U>Exhibit A</U>
and incorporated by this reference as though fully set forth herein. Executive agrees that his signature on this Agreement also serves
as his signature to <U>Exhibit A</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B>Integration</B>. This Agreement contains the entire agreement of the parties relating to the subject matter of this Agreement,
except the Arbitration Agreement which is incorporated herein as set forth <U>Section 10(c)</U> and attached as <U>Exhibit A</U>, and
supersedes all prior oral and written employment agreements or arrangements between the Parties, including the Prior Agreement; <U>provided</U>,
that except as otherwise expressly stated in this Agreement, incentive awards granted to Executive shall be governed by the relevant plan
and any other related grant or award agreement and any other related documents. This Agreement cannot be amended or modified except by
a written agreement signed by Executive and the Company as approved by the Compensation Committee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B>Waiver</B>. No term, covenant or condition of this Agreement or any breach thereof shall be deemed waived, except with the written
consent of the Party against whom the waiver is claimed, and any waiver of any such term, covenant, condition or breach shall not be deemed
to be a waiver of any preceding or succeeding breach of the same or any other term, covenant, condition or breach. No failure to exercise,
delay in exercising, or single or partial exercise of any right, power or remedy by either party hereto shall constitute a waiver thereof
or shall preclude any other or further exercise of the same or any other right, power or remedy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B>Severability</B>. The unenforceability, invalidity, or illegality of any provision of this Agreement shall not render any other
provision of this Agreement unenforceable, invalid or illegal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(g)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B>Interpretation; Construction</B>. The headings set forth in this Agreement are for convenience only and shall not be used in
interpreting this Agreement. The Parties acknowledge that each Party and its counsel have reviewed and revised, or had an opportunity
to review and revise, this Agreement, and the normal rule of construction to the effect any ambiguities are to be resolved against the
drafting party shall not be employed in the interpretation of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(h)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B>Injunctive Relief</B>. In the event that Executive breaches any restrictive covenant, the Company shall be entitled to an injunction
restraining Executive from violating such restrictive covenant (without posting any bond or other security). The Parties agree that the
Arbitration Agreement in <U>Exhibit A</U> shall not preclude either Party from seeking temporary injunctive relief relating to the post-employment
restrictive covenants from a court of appropriate jurisdiction (with the matter then proceeding to arbitration after resolution of the
temporary injunction request). If the Company institutes any action or proceeding to enforce any such restrictive covenant, Executive
hereby waives the claim or defense that the Company has an adequate remedy at law and agrees not to assert in any such action or proceeding
the claim or defense that the Company has an adequate remedy at law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B>Attorneys&rsquo; Fees</B>. In any controversy or claim arising out of or relating to this Agreement or the breach thereof, which
results in legal action, proceeding or arbitration, the prevailing party in such action, as determined by the court or arbitrator, shall
be entitled to recover reasonable attorneys&rsquo; fees and costs incurred in such action.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(j)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B>Counterparts</B>. This Agreement may be executed in any number of counterparts, each of which when so executed and delivered
shall together constitute an original thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(k)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B>Representations and Warranties</B>. Executive represents and warrants that he is not restricted or prohibited, contractually
or otherwise, from entering into and performing each of the terms and covenants contained in this Agreement, and that his execution and
performance of this Agreement will not violate or breach any other agreement between Executive and any other person or entity. Executive
affirms that he has no agreement with any other party that would preclude his compliance with any obligations under this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(l)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B>Preservation of Property</B>. Executive will exercise reasonable care, consistent with good business judgment to preserve in
good working order, subject to reasonable wear and tear from authorized usage, and to prevent loss of, any equipment, instruments or accessories
of the Company in his custody for the purpose of conducting the business of the Company. Upon request, Executive will promptly surrender
the same to the Company at the conclusion of his employment, or if not surrendered, Executive will account to the Company to its reasonable
satisfaction as to the present location of all such instruments or accessories and the business purpose for their placement at such location.
At the conclusion of Executive&rsquo;s employment with the Company, he agrees to return such instruments or accessories to the Company
or to account for same to the Company&rsquo;s reasonable satisfaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>(Signature page follows)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I></I></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I><BR STYLE="clear: both">
</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>IN WITNESS WHEREOF</B>,
the Parties have executed this Agreement as of the Effective Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">CRYOPORT, INC.</TD>
    <TD>&nbsp;</TD>
    <TD>EXECUTIVE:</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 6%">&nbsp;</TD>
    <TD STYLE="width: 44%">&nbsp;</TD>
    <TD STYLE="width: 10%">&nbsp;</TD>
    <TD STYLE="width: 40%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid">/s/Jerrell W. Shelton</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">/s/Robert S. Stefanovich</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Name:</TD>
    <TD>Jerrell W. Shelton</TD>
    <TD>&nbsp;</TD>
    <TD>Robert S. Stefanovich</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Title:</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Chairman, President &amp; Chief Executive Officer</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<!-- Field: Page; Sequence: 12; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
<P STYLE="margin: 0; text-align: left"><B>&nbsp;</B></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>4
<FILENAME>tm246433d1_ex10-3.htm
<DESCRIPTION>EXHIBIT 10.3
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Exhibit 10.3</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">AMENDED AND RESTATED EMPLOYMENT AGREEMENT</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Amended and Restated
Employment Agreement (the &ldquo;<B>Agreement</B>&rdquo;) is made and entered into effective as of February 15, 2024 (the &ldquo;<B>Effective
Date</B>&rdquo;) by and between Cryoport, Inc., a Nevada corporation (the &ldquo;<B>Company</B>&rdquo;), and Mark Sawicki (&ldquo;<B>Executive</B>&rdquo;).
The Company and Executive are hereinafter collectively referred to as the &ldquo;<B>Parties</B>,&rdquo; and individually referred to as
a &ldquo;<B>Party</B>.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">RECITALS</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Parties entered into that certain Employment Agreement effective as of March 15, 2022 between the Company (the &ldquo;<B>Prior Agreement</B>&rdquo;);
and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">B.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company and Executive desire to enter into this Agreement to modify certain terms of the Prior Agreement by amending and restating such
agreement with the terms as set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">AGREEMENT</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>NOW</B>, <B>THEREFORE</B>,
in consideration of the mutual promises and covenants contained herein and for other good and valuable consideration, the receipt and
sufficiency of which are hereby acknowledged, the parties hereto agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><B><U>Employment</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Company hereby employs Executive, and Executive hereby accepts employment by the Company, upon the terms and conditions set
forth in this Agreement for the period beginning on the Effective Date. Executive shall be an at-will employee meaning that Executive&rsquo;s
Employment may be terminated by Executive or by Employer, for any reason or for no reason and with or without Cause (as defined below).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Executive shall serve as Chief Scientific Officer of the Company and the Chief Executive Officer of Cryoport Systems, LLC and shall
have the normal duties, responsibilities, and authority of such office commensurate with the duties, authorities, and responsibilities
of persons in similar capacities in similarly sized companies, unless otherwise determined from time-to-time by the Company&rsquo;s Chief
Executive Officer (&ldquo;<B>CEO</B>&rdquo;). Executive shall do and perform all services, acts, or responsibilities necessary or advisable
to carry out the duties of Chief Scientific Officer of the Company and the Chief Executive Officer of Cryoport Systems, LLC, as assigned
by the Company; provided, however, that at all times during his employment Executive shall be subject to the direction and/or policies
established from time to time by the CEO.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Executive agrees that if Executive&rsquo;s employment is terminated for any reason whatsoever, Executive will resign, at the Company&rsquo;s
request, from any positions Executive has as an officer or director of the Company and of any of the Company&rsquo;s direct or indirect
subsidiaries and any other entity in which Executive is serving as an officer or director relating to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><B><U>Loyal and Conscientious Performance</U></B>. During his employment with the Company, Executive shall devote sufficient energy,
abilities, and productive time to the proper and efficient performance of this Agreement necessary to properly carry out the duties of
Chief Scientific Officer of the Company and the Chief Executive Officer of Cryoport Systems, LLC. Executive may not serve on the board
of directors of any other company without the prior approval of the CEO.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><B><U>Compensation</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><B>Base Salary</B>. The Company shall pay Executive an annual base salary in the amount as determined by the CEO and recommended
to the Board by the CEO and approved by the Compensation Committee of the Board of the Company (the &ldquo;<B>Compensation Committee</B>&rdquo;
and the &ldquo;<B>Base Salary</B>&rdquo;), subject to standard payroll deductions and withholdings, and payable in accordance with the
Company&rsquo;s normal payroll practices. Notwithstanding the foregoing, the Base Salary may be reduced at the Company&rsquo;s discretion
as part of a company-wide austerity measure or a compliance initiative that applies uniformly to all senior executives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><B>Incentive Compensation</B>. In addition to the Base Salary, Executive shall be eligible to participate in the Management Incentive
Plan (MIP) adopted by the Company from time to time in the amounts and at the times determined by the CEO and approved by the Compensation
Committee. Additionally, Executive is also eligible to participate in the Company equity incentive program. Any stock options or other
equity awards that Executive has previously been granted by the Company shall continue to be governed in all respects by the terms of
their applicable grant agreements, grant notices and plan documents. For the avoidance of doubt, the MIP, the equity incentive program,
and any other incentive compensation program implemented by the Company may be modified, replaced, or terminated in the future at the
discretion of the Compensation Committee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><B>Additional Benefits</B>. In addition to the Base Salary payable to Executive hereunder, Executive shall be entitled to the following
benefits:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Except as specifically provided herein, all benefits to which all other executive officers of the Company generally are entitled
as determined by the Board, on terms comparable thereto, including but not limited to, participation in any and all 401(k) plans, bonus
and incentive payment programs, group life insurance policies and plans, medical, health, dental and disability insurance policies and
plans, and the like, which may be maintained by the Company for the benefit of its executive officers, and which participation shall be
governed in all respects by the terms of the applicable benefit plan documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>During Executive&rsquo;s employment with the Company, Executive shall be entitled to paid vacation time in accordance with the
Company&rsquo;s normal and customary policies and procedures now in force or as such policies and procedures may be modified with respect
to senior executive officers of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Company shall reimburse Executive for all reasonable out-of-pocket business expenses incurred by him in the course of performing
his duties under this Agreement, which are consistent with the Company&rsquo;s policies in effect from time to time with respect to travel,
entertainment and other business expenses, subject to the Company&rsquo;s requirements with respect to reporting and documentation of
such expenses pursuant to Company policy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><B>Withholding and Taxes</B>. All of Executive&rsquo;s compensation shall be subject to customary federal and state withholding
taxes and any other employment taxes as are commonly required to be collected or withheld by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><B><U>Term</U></B>.<FONT STYLE="background-color: white">&nbsp; The initial term of this Agreement shall be for a period beginning
on the Effective Date and ending on the third (3<SUP>rd</SUP>) anniversary of the Effective Date (the &ldquo;<B>Initial Term</B>&rdquo;)
or, if earlier, the termination date of Executive&rsquo;s employment in accordance with the provisions set forth in this Agreement. At
the expiration (but not earlier termination) of the Initial Term, and any subsequent Renewal Term (as defined below), the term of this
Agreement shall automatically renew for additional periods of one (1) year (each, a &ldquo;<B>Renewal Term</B>&rdquo;), unless Executive&rsquo;s
employment has earlier terminated or either party hereto has given the other party written notice of non-renewal at least one hundred
and eighty (180) days prior to the expiration date of the Initial Term or the Renewal Term, as applicable. If the Company gives Executive
written notice of non-renewal, the expiration of the Term or the Renewal Term (as applicable) shall be deemed to be the termination of
Executive by the Company without Cause for all purposes under this Agreement as of such date of expiration.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><B><U>Early Termination</U></B>. This Agreement may be terminated early by the following means:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><B>Termination for Cause</B>. The Company may terminate this Agreement for Cause (as defined herein) by delivering written notice
to Executive specifying the cause or causes relied upon for such termination. The termination will be effective immediately unless the
Company specifies a different date in the notice. If Executive&rsquo;s employment under this Agreement is terminated by the Company for
Cause, Executive&rsquo;s Base Salary shall immediately cease and Executive shall be entitled to: (i) Executive&rsquo;s earned and unpaid
Base Salary through the termination date; (ii) reimbursement for any reasonable accrued (but unpaid) expenses through the termination
date; (iii) any accrued but unused vacation time; and (iv) the vested employee benefits, if any, to which Executive is entitled pursuant
to the terms and conditions of the Company&rsquo;s benefit plans (the &ldquo;<B>Accrued Obligations</B>&rdquo;). Grounds for the Company
to terminate this Agreement for &ldquo;<B>Cause</B>&rdquo; shall include only the occurrence of any of the following events:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT> Executive&rsquo;s willful misconduct or gross negligence in the performance of his duties hereunder;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT> Executive&rsquo;s willful failure or refusal to perform in the usual manner at the usual time those duties which he regularly
and routinely performs in connection with the business of the Company or such other duties reasonably related to the capacity in which
he is employed hereunder which may be assigned to him by the CEO or any act or omission that constitutes a material breach of this Agreement,
if such failure, refusal, or breach has not been substantially cured to the satisfaction of the CEO within thirty (30) days after written
notice of such failure or refusal has been given by the Company to Executive;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT> Executive&rsquo;s performance of any action when specifically and reasonably instructed not to do so by the CEO;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iv)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT> Executive&rsquo;s engaging or in any manner participating in any activity which is directly competitive with or intentionally
injurious to the Company (including, without limitation, Executive&rsquo;s violation of any Company policy involving harassment, discrimination,
intellectual property, confidentiality, non-competition, or non-solicitation);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(v)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT> Executive&rsquo;s commission of any fraud against the Company or use or appropriation for his personal use or benefit of any funds
or properties of the Company not authorized by the Board to be so used or appropriated; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(vi)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT> Executive&rsquo;s conviction of any crime involving moral turpitude, dishonesty, theft, fraud, or embezzlement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><B>Termination Without Cause or For Good Reason</B>. The Company may voluntarily terminate this Agreement without Cause by giving
written notice to Executive. Any such notice shall specify the exact date of termination (the &ldquo;<B>Termination Date</B>&rdquo;).
Executive may voluntarily terminate this agreement for Good Reason by giving written notice to the Company specifying the exact Termination
Date. &ldquo;<B>Good Reason</B>&rdquo; means any of the following (i) a material diminution by the Company of Executive&rsquo;s then existing
base salary or non-equity incentive compensation opportunity, other than as contemplated by <U>Section 3(a)</U>; (ii) a material diminution
in Executive&rsquo;s authorities, duties and/or responsibilities; or (iii) the Company&rsquo;s decision to permanently relocate Executive&rsquo;s
residence or the Company&rsquo;s principal business office by more than sixty (60) miles from its then current location and the Executive&rsquo;s
relocation with respect thereto; provided, however, that no termination by Executive shall constitute a termination for Good Reason unless:
(1) Executive gives the Company notice of the existence of the condition constituting Good Reason within thirty (30) days following the
initial occurrence thereof; (2) the Company does not remedy or cure the Good Reason condition within thirty (30) days of receiving such
notice described in (1); and (3) Executive terminates employment within thirty (30) days following the end of the cure period described
in (2). If Executive&rsquo;s employment under this Agreement is terminated by the Company without Cause or by Executive for Good Reason,
subject to the condition set forth below in <U>Section 5(c)</U>, Executive shall be entitled to receive, after the Termination Date, the
Accrued Obligations and the following &ldquo;<B>Severance Benefits</B>&rdquo;: (i) eighteen (18) months of his Base Salary at the rate
existing on the Termination Date; (ii) if Executive timely elects continued coverage under the Consolidated Omnibus Budget Reconciliation
Act of 1985 (&ldquo;<B>COBRA</B>&rdquo;) or any state equivalent, for himself and his covered dependents under the Company&rsquo;s group
health plans following such termination, then the Company shall pay the same portion of the monthly premium under COBRA as it pays for
active employees and their eligible dependents&nbsp;from the Termination Date until the earliest of (A) the date that is eighteen (18)
months after the Termination Date, (B) the expiration of Executive&rsquo;s eligibility for continuation coverage under COBRA, or (C) the
date when Executive becomes eligible for substantially equivalent health insurance coverage in connection with new employment or self-employment
(such period from the termination date through the earliest of (A) through (C), the &ldquo;<B>COBRA Payment Period</B>&rdquo;); and (iii)
with respect to Awards (as defined in the Company&rsquo;s 2018 Omnibus Equity Incentive Plan then held by Executive and not vested as
of the Termination Date, accelerated vesting of such Awards such that Executive gets twelve (12) full months of vesting credit from the
Termination Date; provided that, if the Termination Date is in connection with or within twelve (12) months after a &ldquo;Change in Control&rdquo;
(as defined in the Plan), then all of the Awards then held by Executive and not vested at the time of such termination shall become fully
vested and exercisable as of the Termination Date. With respect to payment of COBRA premiums described above, Executive must pay his portion
of any premiums with after-tax income and any portion of such premiums paid for by the Company shall be fully taxable to Executive. If
Executive becomes eligible for coverage under another employer&rsquo;s group health plan, through self-employment, or otherwise ceases
to be eligible for COBRA coverage during the period provided in this Section, Executive must immediately notify the Company of such event,
and the Company&rsquo;s obligation to pay COBRA premiums on Executive&rsquo;s behalf shall cease. Notwithstanding the foregoing, if at
any time the Company determines, in its sole discretion, that its payment of COBRA premiums on Executive&rsquo;s behalf would result in
a violation of applicable law (including, without limitation, Section 2716 of the Public Health Service Act), then in lieu of paying COBRA
premiums on Executive&rsquo;s behalf, the Company will pay Executive on the last day of each remaining month of the COBRA Payment Period
a cash payment equal to the COBRA premium for that month, which payment shall be subject to applicable tax withholding (such amount, the
 &ldquo;<B>Special Severance Payment</B>&rdquo;), such Special Severance Payment to be made without regard to Executive&rsquo;s payment
of COBRA premiums and without regard to the expiration of the COBRA Payment Period prior to the end of the COBRA continuation period.
Such Special Severance Payment shall end on the earlier of (i)&nbsp;the date on which Executive commences other full-time, regular employment
(i.e., excluding temporary or consulting positions) and (ii) the close or termination of the COBRA continuation period following Executive&rsquo;s
termination. All Base Salary payments shall be paid over time in accordance with the Company&rsquo;s general payroll practices, as and
when such Base Salary would have been paid had Executive&rsquo;s employment not terminated, with the first Base Salary installment due
for the payroll period beginning immediately following the expiration of the separation agreement revocation period described below. Executive
shall not be under any obligation to mitigate the Company&rsquo;s obligation by securing other employment or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><B>Conditions to Receipt of Severance Benefits</B>. The receipt of the Severance Benefits in <U>Section 5(b)</U> will be subject
to and conditioned on Executive&rsquo;s signing and not revoking a separation agreement and release of claims in a form reasonably satisfactory
to the Company (the &ldquo;<B>Separation Agreement</B>&rdquo;) so that such Separation Agreement becomes effective no later than forty-five
(45) days following Executive&rsquo;s Termination Date. Executive will have twenty-one (21) days to consider the Separation Agreement
and seven (7) days to revoke the Separation Agreement after signature on the Separation Agreement. For sake of clarity, no Severance Benefits
will be paid or provided until the Separation Agreement becomes effective. If any Severance Benefits under this Agreement (including the
Base Salary continuation) are not covered by one or more exemptions from the application of Section 409A of the Internal Revenue Code
of 1986, as amended (&ldquo;<B>Section 409A</B>&rdquo;) and the Separation Agreement could become effective in the calendar year following
the calendar year in which Executive&rsquo;s Termination Date occurs, then no Severance Benefits shall begin to be paid until the second
calendar year. Payments deferred pursuant to this Section shall be paid in a lump sum to Executive, and any remaining payments due shall
be paid as otherwise provided in Section 5(b), above. No interest shall be due on any amounts so deferred.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><B>Termination by Executive</B>. Executive may voluntarily terminate this Agreement without Good Reason upon a ninety (90) day
written notice of such termination submitted to the CEO, and in such event, Executive shall only be entitled to receive the Accrued Obligations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT> <B>Termination upon Death or Disability</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>This Agreement shall terminate without notice upon the date of Executive&rsquo;s death or the date when Executive becomes &ldquo;completely
disabled&rdquo; as that term is defined in <U>Section 5(e)(ii)</U>. In the event of Executive&rsquo;s death or compete disability, all
rights of Executive to compensation hereunder shall automatically terminate immediately upon his death or complete disability, except
that Executive&rsquo;s estate or Executive shall be entitled to the Accrued Obligations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The term &ldquo;<B>completely disabled</B>&rdquo; as used in this Agreement shall mean the inability of Executive to perform his
duties under this Agreement because he has become permanently disabled within the meaning of any policy and disability income insurance
covering executives of the Company then in force. In the event the Company has no policy of disability income insurance covering executives
of the Company in force when Executive becomes disabled, the term &ldquo;completely disabled&rdquo; shall mean the inability of Executive
to perform his normal and customary duties under this Agreement for a total of four (4) consecutive months by reason of any incapacity,
physical or mental, based upon medical advice or an opinion provided by a licensed, American Board of Medical Specialties (ABMS) Board-Certified
physician acceptable to the Board. The action of the Board shall be final and binding and the date such action is taken shall be the date
of such complete disability for purposes of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><B><U>Section 409A</U></B>. Notwithstanding anything set forth in this Agreement to the contrary, any payments and benefits provided
pursuant to this Agreement which constitute &ldquo;deferred compensation&rdquo; within the meaning of the Treasury Regulations issued
pursuant to Section 409A shall not commence until Executive has incurred a &ldquo;separation from service&rdquo; (as such term is defined
in the Treasury Regulation Section 1.409A-1(h) (&ldquo;<B>Separation From Service</B>&rdquo;), unless the Company reasonably determines
that such amounts may be provided to Executive without causing Executive to incur the additional twenty percent (20%) tax under Section
409A. It is intended that all of the Severance Benefits and other payments payable under this Agreement satisfy, to the greatest extent
possible, the exemptions from the application of Section 409A provided under Treasury Regulations 1.409A-1(b)(4), 1.409A-1(b)(5) and 1.409A-1(b)(9),
and this Agreement will be construed to the greatest extent possible as consistent with those provisions, and to the extent not so exempt,
this Agreement (and any definitions hereunder) will be construed in a manner that complies with Section 409A. Nevertheless, the Company
does not and cannot guarantee any particular tax effect or treatment of the amounts due under this Agreement. Except for the Company&rsquo;s
responsibility to withhold applicable income and employment taxes from compensation paid or provided to Executive, the Company will not
be responsible for the payment of any applicable taxes on compensation paid or provided pursuant to this Agreement. For purposes of Section
409A (including, without limitation, for purposes of Treasury Regulation Section 1.409A-2(b)(2)(iii)), Executive&rsquo;s right to receive
any installment payments under this Agreement (whether Severance Payments, reimbursements or otherwise) shall be treated as a right to
receive a series of separate and distinct payments. Notwithstanding any provision to the contrary in this Agreement, if Executive is deemed
by the Company at the time of Executive&rsquo;s Separation from Service to be a &ldquo;specified employee&rdquo; for purposes of Code
Section 409A(a)(2)(B)(i), and if any of the payments upon Separation from Service set forth herein and/or under any other agreement with
the Company are deemed to be &ldquo;deferred compensation,&rdquo; then to the extent delayed commencement of any portion of such payments
is required in order to avoid causing Executive to incur the additional twenty percent (20%) tax under Section 409A, such payments shall
not be provided to Executive prior to the earliest of (i) the first business day of the seventh (7<SUP>th</SUP>) month following Executive&rsquo;s
Separation from Service with the Company, (ii) the date of Executive&rsquo;s death, or (iii) such earlier date as permitted under Section
409A without the imposition of adverse taxation. All payments deferred pursuant to this Section shall be paid in a lump sum to Executive
on the first business day of the seventh (7<SUP>th</SUP>) month following Executive&rsquo;s Separation from Service, and any remaining
payments due shall be paid as otherwise provided in Section 5(b), above. No interest shall be due on any amounts so deferred. Notwithstanding
any other provision of this Agreement to the contrary, neither the time nor schedule of any payment under this Agreement may be accelerated
or subject to further deferral except as permitted by Section 409A. Executive does not have any right to make any election regarding the
time or form of any payment due under this Agreement. Any expenses that are to be reimbursed pursuant to this Agreement that are subject
to Section 409A shall: (i) be paid no later than the last day of Executive&rsquo;s tax year following the tax year in which the expense
was incurred; (ii) not affect or be affected by any other expenses that are eligible for reimbursement in any other tax year of Executive;
and (iii) not be subject to liquidation or exchange for any other benefit.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">7.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><B><U>Non-Solicitation</U></B>. Executive agrees that during the period of his employment with the Company and for eighteen (18)
months after the date Executive&rsquo;s employment is terminated for any reason, Executive will not, either directly or through others,
solicit or encourage or attempt to solicit or encourage any employee, independent contractor, or consultant of the Company to terminate
his or her relationship with the Company in order to become an employee, consultant or independent contractor to or for any other person
or entity. This Section survives the termination of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">8.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><B><U>Compensation Recovery</U></B>. By signing this Agreement, Executive agrees to be bound by, and comply with the terms of the
compensation recovery policy or policies (and related practices) of the Company or its affiliates as such may be in effect from time-to-time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">9.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><B><U>Trade Secrets, Confidential Information and Inventions</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><B>Trade Secrets in General</B>. During the course of Executive&rsquo;s employment, Executive will have access to various trade
secrets, confidential information and inventions of the Company as defined below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&ldquo;<B>Confidential Information</B>&rdquo; means all information and material which is proprietary to the Company or any former,
present, or future parent, subsidiary, affiliate, successor, or assign of Company, whether or not marked as &ldquo;confidential&rdquo;
or &ldquo;proprietary&rdquo; and which is disclosed to or obtained from the Company by Executive or developed, created, or discovered
by Executive in his official capacity with the Company, which relates to the Company&rsquo;s past, present or future research, development
or business activities. Confidential Information is all information or materials prepared by or for the Company which information or materials
has commercial value in the business in which the Company is engaged and includes, without limitation, all of the following: designs,
drawings, specifications, techniques, models, data, source code, object code, documentation, diagrams, flow charts, research, development,
processes, systems, methods, machinery, procedures, &ldquo;know-how&rdquo;, new product or new technology information, formulas, patents,
patent applications, product prototypes, product copies, copyrights, possible transactions with other companies, actual or potential mergers
and acquisitions, equity issuances, cost of production, manufacturing, developing or marketing techniques and materials, cost of production,
development or marketing time tables, customer lists, strategies related to customers, suppliers or personnel, contract forms, pricing
policies and financial information, volumes of sales, and other information of similar nature, whether or not reduced to writing or other
tangible form, and any other Trade Secrets, as defined by subparagraph (iii), or non-public business information. Confidential Information
does not include any information which (1) was in the lawful and unrestricted possession of Executive prior to its disclosure by the Company,
(2) is or becomes generally available to the public by acts other than those of Executive (or anyone acting on his behalf) after receiving
it, (3) becomes generally available to the public by acts of Executive necessary to performing duties associated with their job description,
or (4) has been received lawfully and in good faith by Executive from a third party who did not derive it from the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&ldquo;<B>Inventions</B>&rdquo; means all discoveries, concepts, and ideas, whether patentable or not, including but not limited
to, processes, methods, formulas, compositions, techniques, articles and machines, as well as improvements and derivative works thereof
or &ldquo;know-how&rdquo; related thereto, relating at the time of conception or reduction to practice to the business engaged in by the
Company, or any actual or anticipated research or development by the Company. Inventions do not include any subject matter which qualifies
fully under the provisions of California Labor Code Section 2870, including any idea or invention which is developed entirely on Executive&rsquo;s
own time without using the Company&rsquo;s equipment, supplies, facilities, or Trade Secret information, and which is not related to the
Company&rsquo;s business, or actual or demonstrably anticipated research or development of the Company, and which does not result from
any work performed by Executive for the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&ldquo;<B>Trade Secrets</B>&rdquo; shall mean any scientific, technical, or other data, information, design, process, procedure,
formula or improvement that is commercially available to the Company, that is not generally known in the industry, and that derives independent
economic value, actual or potential, from not being generally known to or readily ascertainable through appropriate means by other persons
who might obtain economic value from its disclosure or use.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Section includes not
only information belonging to the Company which existed before the date of this Agreement, but also information developed by Executive
for the Company or its employees during his employment and thereafter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><B>Restriction on Use of Confidential Information</B>. Executive agrees that his use of Trade Secrets and other Confidential Information
is subject to the following restrictions during the term of the Agreement and for an indefinite period thereafter so long as the Trade
Secrets and other Confidential Information have not become generally known to the public.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><B>Non-Disclosure</B>. Except as required by the performance of Executive&rsquo;s services to the Company under the terms of this
Agreement, neither Executive nor any of his agents or representatives, shall, directly or indirectly, publish or otherwise disclose, or
permit others to publish, divulge, disseminate, copy or otherwise disclose the Company&rsquo;s Trade Secrets, Confidential Information
and/or Inventions during or after the term of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><B>Use Restriction</B>. Executive shall use the Trade Secrets, other Confidential Information and/or Inventions only for the limited
purpose for which they were disclosed. Executive shall not disclose the Trade Secrets, other Confidential Information and/or Inventions
to any third party without first obtaining written consent from the Board and shall disclose the Trade Secrets, other Confidential Information
and/or Inventions only to the Company&rsquo;s own employees having a need to know. Executive shall promptly notify the Board of any items
of Trade Secrets prematurely disclosed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><B>Surrender Upon Termination</B>. Upon termination of his employment with the Company for any reason, Executive will surrender
and return to the Company all documents and materials in his possession or control which contain Trade Secrets, Inventions, and other
Confidential Information. Executive shall immediately return to the Company all lists, books, records, materials, and documents, together
with all copies thereof, and all other Company property in his possession or under his control, relating to or used in connection with
the past, present or anticipated business of the Company, or any affiliate or subsidiary thereof. Executive acknowledges and agrees that
all such lists, books, records, materials, and documents, are the sole and exclusive property of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><B>Prohibition Against Unfair Competition</B>. At any time after the termination of his employment with the Company for any reason,
Executive will not engage in competition with the Company while making use of the Trade Secrets of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(g)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><B>Patents and Inventions</B>. Executive agrees that any inventions made, conceived or completed by him during the term of his
service, solely or jointly with others, which are made with the Company&rsquo;s equipment, supplies, facilities or Confidential Information,
or which relate at the time of conception or reduction to purpose of the Invention to the business of the Company or the Company&rsquo;s
actual or demonstrably anticipated research and development, or which result from any work performed by Executive for the Company, shall
be the sole and exclusive property of the Company. Executive promises to assign such inventions to the Company. Executive also agrees
that the Company shall have the right to keep such inventions as Trade Secrets, if the Company chooses. Executive agrees to assign to
the Company Executive&rsquo;s rights in any other inventions where the Company is required to grant those rights to the United States
government or any agency thereof. In order to permit the Company to claim rights to which it may be entitled, Executive agrees to disclose
to the Company in confidence all inventions which Executive makes arising out of Executive&rsquo;s service and all patent applications
filed by Executive within one year after the termination of his service. Executive shall assist the Company in obtaining patents on all
inventions, designs, improvements and discoveries patentable by the Company in the United States and in all foreign countries and shall
execute all documents and do all things necessary to obtain letters patent, to vest the Company with full and extensive title thereto
during and after the term of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(h)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><B>Government Agency Exception. </B>Nothing in this Agreement precludes Executive from filing a charge or complaint with, or participating
in any investigation or proceeding before, or reporting possible violations to, the Equal Employment Opportunity Commission (&ldquo;<U>EEOC</U>&rdquo;),
the National Labor Relations Board (&ldquo;<U>NLRB</U>&rdquo;), the Occupational Safety and Health Administration (&ldquo;<U>OSHA</U>&rdquo;),
the Securities and Exchange Commission (&ldquo;<U>SEC</U>&rdquo;), or any other federal, state or local governmental agency or commission
(&ldquo;<U>Government Agencies</U>&rdquo;).&nbsp; Executive further understands that this Agreement does not limit Executive&rsquo;s ability
to communicate with the Government Agencies or otherwise participate in any investigation or proceeding that may be conducted by any Government
Agency, including providing documents or other information, without notice to the Company, or prohibit Executive from participating in
activities that are protected under whistleblower provisions of federal law or regulation.&nbsp; This Agreement does not limit Executive&rsquo;s
right to receive an award for information provided to the SEC under SEC Rule 21F-17. Executive also confirms that he understands that
nothing in this Agreement prohibits him from reporting to any governmental authority information concerning possible violations of law
or regulation and that Executive may disclose trade secret information to a government official or to an attorney and use it in certain
court proceedings without fear of prosecution or liability provided Executive does so consistent with 18 U.S.C. 1833(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><B>Cooperation</B>. Following the termination of Executive&rsquo;s employment for any reason, Executive will cooperate fully with
the Company and with the Company&rsquo;s counsel in connection with any present and future actual or threatened litigation, administrative
proceeding or other investigation involving the Company that relates to events, occurrences or conduct occurring (or claimed to have occurred)
during the term of Executive&rsquo;s employment with the Company. Expenses incurred by Executive, as related to any such requirement,
will be re-imbursed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(j)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><B>Non-Disparagement; Social Media</B>. Executive will not criticize, defame, be derogatory toward or otherwise disparage the Company,
its products, services, or the Company&rsquo;s past, present and future officers, directors, managers, stockholders, members, attorneys,
agents, representatives, employees, or affiliates, or its or their business plans or actions, to any third party, either orally or in
writing; provided, however, that this provision will not preclude Executive from giving truthful testimony in response to a lawful subpoena
or preclude any conduct protected under any state or federal law providing &ldquo;whistleblower&rdquo; protection to Executive. In addition,
on the date of Executive&rsquo;s termination of employment, Executive shall update his profile on social media websites (such as LinkedIn)
to reflect that he is no longer an employee of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(k)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><B>Survival</B>. This Section 9 survives the termination of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">10.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><B><U>Miscellaneous</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><B>Assignment and Binding Effect</B>. This Agreement shall be binding upon and inure to the benefit of Executive and Executive&rsquo;s
heirs, executors, administrators, estate, beneficiaries, and legal representatives. Neither this Agreement nor any rights or obligations
under this Agreement shall be assignable by either party without the prior express written consent of the other party. This Agreement
shall be binding upon and inure to the benefit of the Company and its successors, assigns and legal representatives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><B>Notices</B>. All notices or demands of any kind required or permitted to be given by the Company or Executive under this Agreement
shall be given in writing and shall be personally delivered (and receipted for), or sent by recognized commercial overnight courier, or
mailed by certified mail, return receipt requested, postage prepaid, addressed as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If to the Company:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Corporate Secretary</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Cryoport, Inc.<BR>
112 Westwood Place, Suite 350</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Brentwood, TN 37027</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If to Executive, to the then-current
address on file with the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Any such written notice shall
be deemed received when personally delivered or upon receipt in the event of overnight courier, or three (3) days after its deposit in
the United States mail by certified mail as specified above. Either Party may change its address for notices by giving notice to the other
Party in the manner specified in this Section.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><B>Choice of Law; Arbitration</B>. This Agreement shall be construed and interpreted in accordance with the internal laws of the
State of Tennessee. The Parties agree that any controversy or claim arising out or relating to this Agreement, or the breach hereof, or
arising out of or relating to the employment of Executive and/or the rights, duties or obligations of the Company or of Executive shall
be settled by binding arbitration in accordance with the Arbitration Agreement in the form and substance attached as <U>Exhibit A</U>
and incorporated by this reference as though fully set forth herein. Executive agrees that his signature on this Agreement also serves
as his signature to <U>Exhibit A</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><B>Integration</B>. This Agreement contains the entire agreement of the parties relating to the subject matter of this Agreement,
except the Arbitration Agreement which is incorporated herein as set forth <U>Section 10(c)</U> and attached as <U>Exhibit A</U>, and
supersedes all prior oral and written employment agreements or arrangements between the Parties, including the Prior Agreement; <U>provided</U>,
that except as otherwise expressly stated in this Agreement, incentive awards granted to Executive shall be governed by the relevant plan
and any other related grant or award agreement and any other related documents. This Agreement cannot be amended or modified except by
a written agreement signed by Executive and the Company as approved by the Compensation Committee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><B>Waiver</B>. No term, covenant or condition of this Agreement or any breach thereof shall be deemed waived, except with the written
consent of the Party against whom the waiver is claimed, and any waiver of any such term, covenant, condition or breach shall not be deemed
to be a waiver of any preceding or succeeding breach of the same or any other term, covenant, condition or breach. No failure to exercise,
delay in exercising, or single or partial exercise of any right, power or remedy by either party hereto shall constitute a waiver thereof
or shall preclude any other or further exercise of the same or any other right, power or remedy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><B>Severability</B>. The unenforceability, invalidity, or illegality of any provision of this Agreement shall not render any other
provision of this Agreement unenforceable, invalid or illegal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(g)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><B>Interpretation; Construction</B>. The headings set forth in this Agreement are for convenience only and shall not be used in
interpreting this Agreement. The Parties acknowledge that each Party and its counsel have reviewed and revised, or had an opportunity
to review and revise, this Agreement, and the normal rule of construction to the effect any ambiguities are to be resolved against the
drafting party shall not be employed in the interpretation of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(h)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><B>Injunctive Relief</B>. In the event that Executive breaches any restrictive covenant, the Company shall be entitled to an injunction
restraining Executive from violating such restrictive covenant (without posting any bond or other security). The Parties agree that the
Arbitration Agreement in <U>Exhibit A</U> shall not preclude either Party from seeking temporary injunctive relief relating to the post-employment
restrictive covenants from a court of appropriate jurisdiction (with the matter then proceeding to arbitration after resolution of the
temporary injunction request). If the Company institutes any action or proceeding to enforce any such restrictive covenant, Executive
hereby waives the claim or defense that the Company has an adequate remedy at law and agrees not to assert in any such action or proceeding
the claim or defense that the Company has an adequate remedy at law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><B>Attorneys&rsquo; Fees</B>. In any controversy or claim arising out of or relating to this Agreement or the breach thereof, which
results in legal action, proceeding or arbitration, the prevailing party in such action, as determined by the court or arbitrator, shall
be entitled to recover reasonable attorneys&rsquo; fees and costs incurred in such action.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(j)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><B>Counterparts</B>. This Agreement may be executed in any number of counterparts, each of which when so executed and delivered
shall together constitute an original thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(k)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><B>Representations and Warranties</B>. Executive represents and warrants that he is not restricted or prohibited, contractually
or otherwise, from entering into and performing each of the terms and covenants contained in this Agreement, and that his execution and
performance of this Agreement will not violate or breach any other agreement between Executive and any other person or entity. Executive
affirms that he has no agreement with any other party that would preclude his compliance with any obligations under this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(l)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><B>Preservation of Property</B>. Executive will exercise reasonable care, consistent with good business judgment to preserve in
good working order, subject to reasonable wear and tear from authorized usage, and to prevent loss of, any equipment, instruments or accessories
of the Company in his custody for the purpose of conducting the business of the Company. Upon request, Executive will promptly surrender
the same to the Company at the conclusion of his employment, or if not surrendered, Executive will account to the Company to its reasonable
satisfaction as to the present location of all such instruments or accessories and the business purpose for their placement at such location.
At the conclusion of Executive&rsquo;s employment with the Company, he agrees to return such instruments or accessories to the Company
or to account for same to the Company&rsquo;s reasonable satisfaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>(Signature page follows)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I></I></P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I><BR STYLE="clear: both">
</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>IN WITNESS WHEREOF</B>,
the Parties have executed this Agreement as of the Effective Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD COLSPAN="2">CRYOPORT, INC.</TD>
  <TD>&nbsp;</TD>
  <TD>EXECUTIVE:</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 5%">&nbsp;</TD>
  <TD STYLE="width: 40%">&nbsp;</TD>
  <TD STYLE="width: 5%">&nbsp;</TD>
  <TD STYLE="width: 45%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>By:</TD>
  <TD STYLE="border-bottom: Black 1pt solid">/s/ Jerrell W. Shelton</TD>
  <TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
  <TD STYLE="border-bottom: Black 1pt solid">/s/ Mark Sawicki</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>Name:</TD>
  <TD>Jerrell W. Shelton</TD>
  <TD>&nbsp;</TD>
  <TD>Mark Sawicki</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>Title:</TD>
  <TD>Chairman, President &amp; Chief Executive Officer</TD>
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>cyrx-20240210.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.21a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +aA5w7xRiXgen8uLa3ZcWaWBGbOdzZR+SYkxtmBzbYn6ryoilP1DNynQPgvGcYYE -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:srt-types="http://fasb.org/srt-types/2023" xmlns:cyrx="http://Cryoport.com/20240210" elementFormDefault="qualified" targetNamespace="http://Cryoport.com/20240210">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://Cryoport.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="cyrx-20240210_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="cyrx-20240210_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" />
    <import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" />
    <import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd" />
    <import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd" />
    <import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>cyrx-20240210_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.21a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>cyrx-20240210_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.21a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://Cryoport.com/role/Cover" xlink:href="cyrx-20240210.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://Cryoport.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140279846515664">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Feb. 10, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Feb. 10,  2024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-34632<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">CRYOPORT, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001124524<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">88-0313393<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">NV<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">112 Westwood Place<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 350<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Brentwood<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">TN<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">37027<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">949<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">470-2300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.001 par value<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CYRX<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( $J%3U@'04UB@0   +$    0    9&]C4')O<',O87!P+GAM
M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG
M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGD<Z,STA)8*O4'J@)I9GF
M3?X.CD:?<@X>K7A.YNJQ<&4GPZ4A!0W_<FW>J=0U[R;UEA_6\#MI7E!+ P04
M    " !*A4]8T&3(QNX    K @  $0   &1O8U!R;W!S+V-O<F4N>&ULS9+!
M3L,P#(9?!>7>NLDV#E&7"X@32$A, G&+$F^+:)HH,6KW]K1AZX3@ 3C&_O/Y
ML^361&E"PN<4(B9RF&]&W_59FKAE1Z(H ;(YHM>YGA+]U-R'Y#5-SW2 J,V'
M/B"(IKD%CZ2M)@TSL(H+D:G6&FD2:@KIC+=FP<?/U!68-8 =>NPI Z\Y,#5/
MC*>Q:^$*F&&$R>?O MJ%6*I_8DL'V#DY9K>DAF&HAU7)33MP>'MZ?"GK5J[/
MI'N#TZ_L))TB;MEE\NOJ[G[WP)1HQ+IJ1,4W.\'E6DB^>9]=?_A=A7VP;N_^
ML?%%4+7PZR[4%U!+ P04    " !*A4]8F5R<(Q &  "<)P  $P   'AL+W1H
M96UE+W1H96UE,2YX;6SM6EMSVC@4?N^OT'AG]FT+QC:!MK03<VEVV[29A.U.
M'X416(UL>621A'^_1S80RY8-[9)-NIL\!"SI^\Y%1^?H.'GS[BYBZ(:(E/)X
M8-DOV]:[MR_>X%<R)!%!,!FGK_# "J5,7K5::0##.'W)$Q+#W(*+"$MX%,O6
M7.!;&B\CUNJTV]U6A&ELH1A'9&!]7BQH0-!445IO7R"TY1\S^!7+5(UEHP$3
M5T$FN8BT\OELQ?S:WCYES^DZ'3*!;C ;6"!_SF^GY$Y:B.%4PL3 :F<_5FO'
MT=)(@(+)?90%NDGVH],5"#(-.SJ=6,YV?/;$[9^,RMIT-&T:X./Q>#BVR]*+
M<!P$X%&[GL*=]&R_I$$)M*-IT&38]MJND::JC5-/T_=]W^N;:)P*C5M/TVMW
MW=..B<:MT'@-OO%/A\.NB<:KT'3K:28G_:YKI.D6:$)&X^MZ$A6UY4#3( !8
M<';6S-(#EEXI^G64&MD=N]U!7/!8[CF)$?[&Q036:=(9EC1&<IV0!0X -\31
M3%!\KT&VBN#"DM)<D-;/*;50&@B:R('U1X(AQ=RO_?67N\FD,WJ=?3K.:Y1_
M::L!I^V[F\^3_'/HY)^GD]=-0LYPO"P)\?LC6V&')VX[$W(Z'&="?,_V]I&E
M)3+/[_D*ZTX\9Q]6EK!=S\_DGHQR([O=]EA]]D]';B/7J<"S(M>41B1%G\@M
MNN01.+5)#3(3/PB=AIAJ4!P"I DQEJ&&^+3&K!'@$WVWO@C(WXV(]ZMOFCU7
MH5A)VH3X$$8:XIQSYG/1;/L'I4;1]E6\W*.76!4!EQC?-*HU+,76>)7 \:V<
M/!T3$LV4"P9!AI<D)A*I.7Y-2!/^*Z7:_IS30/"4+R3Z2I&/:;,CIW0FS>@S
M&L%&KQMUAVC2/'K^!?F<-0H<D1L= F<;LT8AA&F[\!ZO)(Z:K<(1*T(^8ADV
M&G*U%H&V<:F$8%H2QM%X3M*T$?Q9K#63/F#([,V1=<[6D0X1DEXW0CYBSHN0
M$;\>ACA*FNVB<5@$_9Y>PTG!Z(++9OVX?H;5,VPLCO='U!=*Y \FIS_I,C0'
MHYI9";V$5FJ?JH<T/J@>,@H%\;D>/N5Z> HWEL:\4*Z">P'_T=HWPJOX@L Y
M?RY]SZ7ON?0]H=*W-R-]9\'3BUO>1FY;Q/NN,=K7-"XH8U=RS<C'5*^3*=@Y
MG\#L_6@^GO'M^MDDA*^:62TC%I!+@;-!)+C\B\KP*L0)Z&1;)0G+5--E-XH2
MGD(;;NE3]4J5U^6ON2BX/%ODZ:^A=#XLS_D\7^>TS0LS0[=R2^JVE+ZU)CA*
M]+',<$X>RPP[9SR2';9WH!TU^_9==N0CI3!3ET.X&D*^ VVZG=PZ.)Z8D;D*
MTU*0;\/YZ<5X&N(YV02Y?9A7;>?8T='[Y\%1L*/O/)8=QXCRHB'NH8:8S\-#
MAWE[7YAGE<90-!1M;*PD+$:W8+C7\2P4X&1@+: '@Z]1 O)256 Q6\8#*Y"B
M?$R,1>APYY=<7^/1DN/;IF6U;J\I=QEM(E(YPFF8$V>KRMYEL<%5'<]56_*P
MOFH]M!5.S_Y9K<B?#!%.%@L22&.4%Z9*HO,94[[G*TG$53B_13.V$I<8O./F
MQW%.4[@2=K8/ C*YNSFI>F4Q9Z;RWRT,"2Q;B%D2XDU=[=7GFYRN>B)V^I=W
MP6#R_7#)1P_E.^=?]%U#KG[VW>/Z;I,[2$R<><41 71% B.5' 86%S+D4.Z2
MD 83 <V4R43P H)DIAR F/H+O?(,N2D5SJT^.7]%+(.&3E[2)1(4BK ,!2$7
M<N/O[Y-J=XS7^BR!;814,F35%\I#B<$],W)#V%0E\Z[:)@N%V^)4S;L:OB9@
M2\-Z;ITM)__;7M0]M!<]1O.CF> >LX=SFWJXPD6L_UC6'ODRWSEPVSK> U[F
M$RQ#I'[!?8J*@!&K8KZZKT_Y)9P[M'OQ@2";_-;;I/;=X Q\U*M:I60K$3]+
M!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F 6/,,H68XWX=%FAHSU8NL.8T*;T'5
M0.4_V]0-:/8--!R1!5XQF;8VH^1."CS<_N\-L,+$CN'MB[\!4$L#!!0    (
M $J%3U@V]>+&4P0   T1   8    >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL
MC9AO<^(V$,:_BL;M=-J9$/\C@:3 #"%)R]P=H4 OO7;Z0M@"-+$E5Y(#^?9=
M&6+3U*QY Y;M??SS[OJ1[-Y6JA>]8<R079H(W7<VQF2WKJNC#4NIOI09$W!D
M)55*#0S5VM698C0N@M+$#3SOVDTI%\Z@5^R;JD%/YB;A@DT5T7F:4O5VQQ*Y
M[3N^\[YCQM<;8W>X@UY&UVS.S._95,'(+55BGC*AN11$L57?&?JW=\&5#2C.
M^,K95A]M$WLK2RE?[& <]QW/$K&$1<9*4/A[92.6)%8)./XYB#KE-6W@\?:[
M^F-Q\W S2ZK92";//#:;OM-U2,Q6-$_,3&Y_98<;*@ CF>CBEVSWY[;;#HER
M;61Z" :"E(O]/]T=$G$4$/HG H)#0%!P[R]44-Y30P<]);=$V;-!S6X4MUI$
M QP7MBISH^ HAS@S&,E7IGJN 2F[PXT.87?[L.!$V"-;7A+?NR"!%[3_&^X"
M08D1E!A!H1=B&.2OX5(;!87ZNXYHK]"N5[#=>ZLS&K&^ ^VIF7IESN"'[_QK
M[V>$+RSY0DQ]<"^C''K1D,5;QNK@\/!NZQ,"T2XAVJC*$ CB@N(QH>LZ"CQ^
M11/-$(ZKDN/JO&1,F>(R)@\B)M!\M7G!E<HV:NJCZQ+M&A5\$(:;-_+($T8F
M>;JL[VU<P_/\5MB^#@.$IU/R=,[AF;$UMYT-.9O0M#91N,YH]NUI^C1;7)#Q
M9'2)@'5+L.XY8",HHZ()&8N8[<@G]E:'ABMYD"\_:%^A];LIL6[.P5K0'1G'
MP,97/**%?9^N)J[8[;:\T _#FQ#!\[W*+KUS ,<BDBJ3JF"[(',#[4^D(B.9
M0T(AKS*NK7*#^N0K!GGDZ?XYD,,X!B?4%^\;Y#.<1YY$/1DN"24FSTR;K80'
M?IJ SV*DE>W[J&OCI(NMK"7%)><YAUJ$5QX&6/F^CSOW1\"1'4&A%W(K:N%P
MN3L%36USB,%5\X&/&_I'N+(-ITJ^<O&Q1@="7',QP="J*<+'G?TCVE1J S[S
M)\]./QNX8MCQ@@[&5LT1/F[P10V'L(8]C8(+W+1O,)!J<O!Q5_\L(\C)=",%
M-ELUB+0[7BL(/;3=JUG!Q\W\67%CF(#$I&DN#MZK:ZEPH::UAE_-"#YNX'.9
M\(@;+M;D"[2WXC2IY<%5FGB":@8(<(^>*M:*(#T,GJ_]DA!69;!X?5JMZNO7
MH-=(5ME^@'OT_\C&6N= U@B(RS8"'BWR<6M>< /K,KDB?O#C\B<R9U$._5:[
MYFA0LOT)BX*YD='+!?G>NX1%",FH(J\TR5'8ROD#W*H7BL:VZ>9OZ5+6MER#
MP.C;[ ^,I++Y +?D]SR1AUVTH6+-3BXB&X0FP_G]\#>,J?+WX"Q_?TB96MLL
M_0(*9F-](Z.BOJ*XX,DN<X]>;NV'@B_47E&3A*U R+OL@*[:OWOO!T9FQ?ON
M4AIX>RXV-XS"$V!/@.,K*<W[P+Y"EU] !O\"4$L#!!0    ( $J%3UB?H!OP
ML0(  .(,   -    >&PO<W1Y;&5S+GAM;-U7;6O;,!#^*T(_8&YB:N*1&+9
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M8*<D3?,\C@ 69Y"F& *G$4<P!L !0])T> \^>Q\ETWLJ.?]74_P$4$L#!!0
M   ( $J%3UB7BKL<P    !,"   +    7W)E;',O+G)E;'.=DKENPS ,0'_%
MT)XP!] AB#-E\18$^0%6H@_8$@6*19V_K]JE<9 +&7D]/!+<'FE [3BDMHNI
M&/T04FE:U;@!2+8ECVG.D4*NU"P>-8?20$3;8T.P6BP^0"X99K>]9!:G<Z17
MB%S7G:4]VR]/06^ KSI,<4)I2$LS#O#-TG\R]_,,-47E2B.56QIXT^7^=N!)
MT:$B6!::1<G3HAVE?QW']I#3Z:]C(K1Z6^CY<6A4"H[<8R6,<6*T_C6"R0_L
M?@!02P,$%     @ 2H5/6*K$(A8S 0  (@(   \   !X;"]W;W)K8F]O:RYX
M;6R-4=%NPC ,_)4J'[ 6M"$-45Y VY"F#8V)]]"ZU"*)*\>%C:^?VZH:TE[V
ME-S9NMQ=%A?BTX'HE'QY%V)N:I%FGJ:QJ,';>$<-!)U4Q-Z*0CZFL6&P9:P!
MQ+MTFF6SU%L,9KD8M;:<W@(2* 0I*-D1>X1+_)UW,#ECQ ,ZE._<]'<')O$8
MT.,5RMQD)HDU75Z(\4I!K-L53,[E9C(,]L""Q1]ZUYG\M(?8,V(/'U:-Y&:6
MJ6"%'*7?Z/6M>CR#+@^H%7I")\!K*_#,U#88CIV,IDAO8O0]C.=0XIS_4R-5
M%1:PIJ+U$&3HD<%U!D.LL8DF"=9#;E9T!N[RZ .;<L@F:NJF*9ZC#GA3#O9&
M3R54&*!\4YFHO/93;#GICEYG>O\P>=0>6N=6RKV'5[+E&''\GN4/4$L#!!0
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ML;S63AI_YHOA/UY_ 5!+ 0(4 Q0    ( $J%3U@'04UB@0   +$    0
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ME@P  'AL+W-T>6QE<RYX;6Q02P$"% ,4    " !*A4]8EXJ[',     3 @
M"P              @ %R#P  7W)E;',O+G)E;'-02P$"% ,4    " !*A4]8
MJL0B%C,!   B @  #P              @ %;$   >&PO=V]R:V)O;VLN>&UL
M4$L! A0#%     @ 2H5/6"0>FZ*M    ^ $  !H              ( !NQ$
M 'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%     @ 2H5/6&60
M>9(9 0  SP,  !,              ( !H!(  %M#;VYT96YT7U1Y<&5S72YX
8;6Q02P4&      D "0 ^ @  ZA,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="tm246433d1_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://Cryoport.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>cyrx-20240210.xsd</File>
    <File>cyrx-20240210_lab.xml</File>
    <File>cyrx-20240210_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="tm246433d1_8k.htm">tm246433d1_8k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "tm246433d1_8k.htm": {
   "nsprefix": "cyrx",
   "nsuri": "http://Cryoport.com/20240210",
   "dts": {
    "schema": {
     "local": [
      "cyrx-20240210.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "cyrx-20240210_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cyrx-20240210_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "tm246433d1_8k.htm"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2023": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 59,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 23
   },
   "report": {
    "R1": {
     "role": "http://Cryoport.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2024-02-10",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm246433d1_8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-02-10",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm246433d1_8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://Cryoport.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://Cryoport.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://Cryoport.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://Cryoport.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://Cryoport.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CountryRegion",
     "presentation": [
      "http://Cryoport.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://Cryoport.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://Cryoport.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://Cryoport.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://Cryoport.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://Cryoport.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://Cryoport.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://Cryoport.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://Cryoport.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://Cryoport.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://Cryoport.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://Cryoport.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://Cryoport.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://Cryoport.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://Cryoport.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://Cryoport.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://Cryoport.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://Cryoport.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://Cryoport.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://Cryoport.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://Cryoport.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://Cryoport.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://Cryoport.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://Cryoport.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://Cryoport.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://Cryoport.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://Cryoport.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://Cryoport.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://Cryoport.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://Cryoport.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://Cryoport.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://Cryoport.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://Cryoport.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://Cryoport.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://Cryoport.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://Cryoport.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://Cryoport.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://Cryoport.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://Cryoport.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://Cryoport.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Extension",
     "presentation": [
      "http://Cryoport.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://Cryoport.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://Cryoport.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://Cryoport.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://Cryoport.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://Cryoport.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://Cryoport.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12gTitle",
     "presentation": [
      "http://Cryoport.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://Cryoport.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://Cryoport.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://Cryoport.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://Cryoport.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://Cryoport.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001104659-24-024562-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001104659-24-024562-xbrl.zip
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M+RMO4G.X&+G52L5SGV\ZO01GI<!Z3 E[707WCH^/W<2;0TO(>"!H+EUSC7L
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MK1<6+C=$K.7T]I/@K]ECF9\5;!N@=LM&I^4F(U9I0*QT^0.8T2&HB-$I=?W
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M )L9S83@\\30W^6-V7VA4JWF6T(-SDH)L%M/E*H7\0EK^=9"2])F+<6I11S
MR3$.RRYSQ7UTI4U7K)& "Q$+7W,B_"1:6R$TD>+,U?/!;0_\P;N\:TP=DZ$/
M"*9)0)93N;;/@YE@D!!X,Z!<$+%$>>"9PI%,4!]>C"X;.MX8&8P3@3A+76XZ
MEQ^3O%E^.)JLE#9;,)<#C+3U%11@P>?>.?58:X%]"&=Q;_DI4)J,9\([2RC%
M9P^O!>Q+L-2W#,E/,*ME)DX9=7W.6H'Y-6%(""J\E8"/L-*!2TO.@A\0+\9L
M.<'"72Q/ K8-@EMA*#XIE)UZ-E_<W9CV9?128,9F/&>6/36L)^9\DA_+DZ:
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M"^8V;[)HE58@Q$8*D!9E4:%B<$&O9R1CSY8CAQGG@8?+1<[O9(NW.T#VY#Y
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M!/)!VXUJ:_G,+[)FM:;[O&JY$WW="EGV<<J\R9D*4*)Y( 9$$IBH$-+?46W
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MD,+JZ-I#6%G^)*)*&M66$@#PU>^VQ1^K!%#)ZD+EI\A9)UZ]$(10*IR@";4
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M86YLT>J7DGVG/(<J\XT'T-T[\$/%M'/8YZ&1-)&$&E<S(04G[#Q@PU3+;"T
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M*>UNG#EHI=UAS5M5D'(6Y%!;>.!?.994IZ8'5^<RKN7!*WG08T"X7G&N9VF
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M7B7#9U-[.33IB25WY1*SI+MNO,; ^H4;<!*UR[((90CS"!(^N.0L3[:W1*!
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MU=<1U*CG;/!EE7G? \2OX$(0@>A30>H9#PQ[""Y[2T"*CA!. 5:H&!3_[>4
MJB>36"3;C9U5F/0%?7"_R.HV:3I/'])T[B)-Y^E#FLY?^>;M7&VR3DHR^2I+
M0I$/46X"2;\HD3W0M-62+*K4L+B?EV050H(3OYTQ. =) 1;?@!'][W^E,N1^
MI91L4L59Z.O_K1.?HR-"J= _@9%XQO;%> B 3K\MFKC*\AO" =W0WY2CEQSR
M[P4M0Y-42[)@VNI?%1!+(@(:T(19[\*JP<OT_*KA>_;QH_?#F.4G7BGN^%2#
MS?$OU8\C]W3M7D!#WN B]&X+DIQ?>^\(K->6HV3C;EGX\P-W1@J5N^5W[[D
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M6UU,7Q!25;96!VI'/"VOPKRB:$%6*_-(=KL*>V2R8<^^'8#WG+=UKXD_P@K
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M18>G8!7[UO!A5YRT,0Z12$+724_C9Z:1MXLE7>I%Q_;S1?#>9G9F VG4,A"
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M&I? _S\K*U\;.])$F/7Q.*_+SO!>$PNU"(_VV0M-^M8#FB#12XG0,EZB)1C
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MB\$.@IJG2$2P0":I>AUJSO"$T#J\!JW+[D.CT1@;GU4',W>0LR=*Q*FNYY'
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MPT)3D\=K>9[UB_ B#I+K]?5(2W =+9AGLOW$V;EH@?FGRV#>^VEW#390JHF
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M,C$P+GAS9%!+ 0(4 Q0    ( $J%3UC]' +[_0H  ("&   5
M  "  5D#  !C>7)X+3(P,C0P,C$P7VQA8BYX;6Q02P$"% ,4    " !*A4]8
M$< EWE@'  #55P  %0              @ &)#@  8WER>"TR,#(T,#(Q,%]P
M<F4N>&UL4$L! A0#%     @ 2H5/6!@';F#=%0  (((  !$
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64$L%!@     '  < S0$  %+>      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>tm246433d1_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="cyrx-20240210.xsd" xlink:type="simple"/>
    <context id="AsOf2024-02-10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124524</identifier>
        </entity>
        <period>
            <startDate>2024-02-10</startDate>
            <endDate>2024-02-10</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2024-02-10" id="ixv-344">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2024-02-10" id="ixv-345">0001124524</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2024-02-10" id="ixv-365">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2024-02-10" id="ixv-366">2024-02-10</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2024-02-10" id="ixv-367">CRYOPORT, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2024-02-10" id="ixv-368">NV</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2024-02-10" id="ixv-369">001-34632</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2024-02-10" id="ixv-370">88-0313393</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2024-02-10" id="ixv-371">112 Westwood Place</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="AsOf2024-02-10" id="ixv-372">Suite 350</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="AsOf2024-02-10" id="ixv-373">Brentwood</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2024-02-10" id="ixv-374">TN</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2024-02-10" id="ixv-375">37027</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2024-02-10" id="ixv-376">949</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2024-02-10" id="ixv-377">470-2300</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2024-02-10" id="ixv-378">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2024-02-10" id="ixv-379">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2024-02-10" id="ixv-380">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2024-02-10" id="ixv-381">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="AsOf2024-02-10" id="ixv-382">Common Stock, $0.001 par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="AsOf2024-02-10" id="ixv-383">CYRX</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="AsOf2024-02-10" id="ixv-384">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2024-02-10" id="ixv-385">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
